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Modular polyketide synthases (PKSs) are the largest enzymes known to man and 
are responsible for synthesizing some of the most important human medicines. Their 
ability to construct stereochemically-rich carbon chains containing diverse substituents 
has inspired the biosynthetic community to engineer these factories for the in vitro 
synthesis of a small library of polyketide compounds. New complex polyketides are 
discovered every year, yet the lack of compound prohibits characterization and testing of 
these new compounds for medicinal properties. Smaller polyketide compounds generated 
in vitro could be organically manipulated to generate larger, more complex polyketide 
natural products and natural product analogs. Chemoenzymatic approaches like this 
would be extremely beneficial to the scientific community; however, there are still 
obstacles that must be overcome before the use of PKS for the preparative synthesis of an 
in vitro generated polyketide library would prove fruitful: purchasing substrates such as 
methylmalonyl-CoA is cost-prohibitive, PKSs are often difficult to express and purify, 
and the products generated are typically nonchromophoric. The use of a malonyl-CoA 
ligase from Streptomyces coelicolor (MatB) was investigated for the enzymatic synthesis 
of polyketide extender units such as methylmalonyl-CoA (Chapter 2). MatB synthesized 
a total of 5 CoA-linked extender units in vitro: malonyl-, methylmalonyl-, ethylmalonyl-, 
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hydroxymalonyl- and methoxymalonyl-CoA. Two ternary complex structures of MatB 
with bound product and leaving group were also solved to sub-2Å resolution. MatB 
generated extender units were employed in the module-catalyzed synthesis of a triketide 
pyrone. The selectivity of a PKS module to incorporate a variety of side chains into 
triketide pyrones was also investigated (Chapter 3). A total of 10 triketide pyrone 
compounds were synthesized, 5 produced via modular “stuttering” and one possessing a 
terminal alkyne chemical handle. Lastly, nonchromphoric polyketide products were made 
visible upon copper(I)-catalyzed azide alkyne cycloaddition (CuAAC) with fluorescent 
sulforhodamine B azide revealing insights into in vitro reactivites of a PKS module 
(Chapter 4). The work described in this dissertation has helped advance the scientific 
community towards procuring an in vitro synthesized polyketide library for future 
synthetic applications. 
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Chapter 1 Introduction 
Due to the ability of polyketide synthases (PKSs) to incorporate a variety of 
functional groups and stereochemistries into a growing polyketide chain (Khosla, 2007; 
Keatinge-Clay, 2013), a longstanding vision of the PKS community has been to harness 
this enzymatic power and produce libraries of stereochemically diverse molecules in 
vitro. Every year, new complex natural products are discovered, yet a lack of synthetic 
compound hinders testing for potential medicinal efficacy. A library of stereoisomeric 
polyketides could serve as chiral synthons to generate stereochemically complex natural 
products and natural product analogs such as bryostatin, concanomycin, soraphen and 
discodermolide (Figure 1-1). A PKS-generated library of complex molecules would 
prove extremely beneficial to the scientific community; however, there are still many 
obstacles that must be overcome before PKSs may be employed in the preparative 
synthesis of diverse molecules in vitro.  
Modular type I PKSs are enzymatic assembly lines responsible for the 
condensation and processing of small carbon building blocks, termed extender units. The 
erythromycin synthase is the most thoroughly studied of all PKSs and may be used as a 
model system when describing the enzymatic synthesis of polyketides (Figure 1-2). A 
loading didomain commences polyketide growth by priming the enzymatic assembly line 
with a propionyl group. Within the following modules, an acyltransferase (AT) selects an 
extender unit, a ketosynthase (KS) catalyzes claisen-like condensation reactions, and 
optional β-carbon processing enzymes, such as a ketoreductase (KR), a dehydratase 
(DH), and an enoylreductase (ER), set the functional groups and stereochemistries at the 
α- and β-carbons. The growing polyketide chain is shuttled through the PKS in a hand-
over-hand fashion via an ~18Å phosphopantetheinyl arm attached to the acyl carrier 
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protein (ACP) of each module. The final polyketide is both hydrolyzed and cyclized from 
the PKS by the thioesterase (TE). After cyclization, tailoring enzymes such as P450 
oxygenases and glycosyl transferase decorate the polyketide with hydroxyl groups and 
sugar moieties to produce the final, biologically-active polyketide. 
The complexity of polyketide natural products largely results from (1) the number 
of modules found within the PKS system, (2) extender unit selection by ATs and (3) KR 
activity. The most common extender units selected for by ATs are malonyl-CoA, (2S)-
methylmalonyl-CoA and (2S)-ethylmalonyl-CoA. More exotic extender units 
incorporated into a growing polyketide chain include (2R)-methoxymalonyl-ACP, (2R)-
hydroxymalonyl-ACP and (2S)-aminomalonyl-ACP (Figure 1-3). These exotic extender 
units are synthesized on the ACP arm by tailoring enzymes found within the PKS gene 
cluster.  
The KR type within each module also has a great influence on polyketide 
complexity. There are six KR types found within modular PKSs: A1, A2, B1, B2, C1 and 
C2 (Figure 1-4). A-type KRs reduce the β-carbonyl to a L-hydroxy group, and B-type 
KRs reduce the β-carbonyl to a D-hydroxy group. C-type KRs are reductase incompetent, 
for they lack the essential active site tyrosine residue. Numerical values associated with 
the KR type is indicative of α-carbon epimerase functionality; type 1 KRs are epimerase 
inactive and leave α-substituents in D-configuration whereas type 2 KRs epimerize α-
substituents to L-configuration. The KRs of modules 1 and 4 in the erythromycin PKS 
(EryKR1 and EryKR4, respectively) are B2 type KRs. EryKR2, EryKR5 and EryKR6 are 
A1 type KRs, while EryKR3 is a C2 type KR (Figure 1-2). 
In addition to the AT extender unit selection and KR type, their modular nature 
makes PKSs desirable for the in vitro generation of complex molecules. Domain 
swapping experiments to generate hybrid modules have been successful in their ability to 
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produce polyketide compounds possessing new functionalities. For example, Oliynyk and 
coworkers demonstrated the formation of a new triketide lactone compound by swapping 
the native (2S)-methylmalonyl-CoA selecting AT for a malony-CoA selecting AT 
(Oliynyk, 1996). Kao and coworkers employed this technique to produce two triketide 
lactones with new stereochemical configurations after swapping the native erythromycin 
PKS A1-type KR for two different non-native B-type KRs from the rapamycin PKS 
(Kao, 1998). In both experiments, the new functionality of the swapped domain was 
incorporated into the polyketide product; however, an overall loss of activity was 
reported for these hybrid enzymes (Oliynyk, 1996; Kao, 1998). This loss was 
hypothesized to result from inter-modular structural interactions. A second, more recent 
approach to generate polyketides possessing new functionalities has been through 
directed evolution. This approach does not alter inter-modular structural interactions, but 
focuses on altering substrate specificity of the native domain within that module. 
Sundermann and coworkers demonstrated the power of this technique by successfully 
evolving EryAT6 to accept a terminal alkyne extender unit (Sundermann, 2012). 
The extraordinary promise of modular PKSs to produce a small library of 
compounds in vitro is apparent; however, there are many challenges associated with 
increasing in vitro polyketide production to a preparative scale: substrates such as 
NADPH and methylmalonyl-CoA are costly, modules are often difficult to express and 
purify, and the products generated are typically nonchromophoric. NADPH is an 
essential cofactor required for KR activity. Fortunately, a glucose-fueled NADPH-
regeneration system has already been developed to provide a constant supply of reduced 
nicotinamide coenzyme (Figure 1-5) (Wong, 1985). In order to reduce financial burden of 
purchased extender units for in vitro production of polyketides, the use of a malonyl-CoA 
ligase from Streptomyces coelicolor (MatB) was investigated (Chapter 2).   
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MatB is an adenylate-forming enzyme that synthesizes malonyl-CoA from ATP, 
Mg2+, malonic acid and CoA. Experiments showed MatB possessed a high substrate 
tolerance toward the diacid incorporated; a total of 5 CoA-linked extender units were 
synthesized: malonyl-, methylmalonyl-, ethylmalonyl-, hydroxymalonyl- and 
methoxymalonyl-CoA. Promiscuity towards the thiol handle was also investigated; 
resulting in the first report of enzymatically synthesized D-pantetheine (PANT-) and N-
acetylcysteamine (NAC-) linked extender units. The terminal module – thioesterase 
complex of the erythromycin PKS (EryMod6TE) was employed for the chemoenzymatic 
synthesis of a triketide pyrone from a diketide-S-NAC priming substrate and MatB 
synthesized CoA-, PANT- and NAC-linked methylmalonyl extender units. In addition to 
enzymatic assays, two ternary-complex structures of MatB were solved using single 
wavelength anomalous dispersion - molecular replacement (SAD-MR), revealing density 
in the active site for the bound product and leaving group (malonyl-CoA or (2R)-
methylmalonyl-CoA and AMP, accession codes 3NYQ and 3NYR, respectively). 
With the ultimate goal of expanding the diversity of an in vitro synthesized 
polyketide library, and having developed an established route to triketide compounds 
from MatB synthesized extender units, the substrate tolerance of EryKS6 from 
EryMod6TE was investigated (Chapter 3). EryMod6TE was incubated with MatB-
generated methylmalonyl-S-NAC and a variety of β–ketoacyl-S-NAC diketide and acyl-
S-NAC monoketide priming substrates (Figure 1-6). EryKS6 demonstrated a high 
substrate tolerance; a total of 10 triketide pyrone compounds were synthesized, 5 
produced via modular “stuttering” and one possessing a terminal alkyne chemical handle. 
“Stuttering” refers to the phenomenon of a single module catalyzing more than one 
condensation reaction. This was the first reported observation of EryMod6 “stuttering.” 
Pyrone product (20 mg) was isolated from a reaction where 200 mg of diketide-S-NAC 
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priming substrate was incubated with MatB produced extender units and dialyzed 
EryMod6TE lysate resulting in an overall 12% yield. It was hypothesized that TE-
catalyzed hydrolysis of priming substrate was the major source for the low percent yield. 
Hoping that a non-native TE would be less active towards substrate hydrolysis, pyrone 
formation was examined for three EryMod6TE hybrid modules where the native EryTE 
was swapped for non-native TEs, two PKS TEs and one non-ribosomal peptide synthase 
(NRPS) TE. A decrease in pyrone production was reported for the domain swapping 
experiments, and the source(s) of the low polyketide product yields remained 
unidentified. Many polyketide products and intermediates do not contain chromophoric 
moieties, making it very difficult to pinpoint where loss of product occurs during 
enzymatic synthesis. With only overall 4-12% yields for triketide product formation with 
our established EryMod6TE system (Harper, 2012; Hughes, 2012), a method utilizing 
copper catalyzed azide-alkyne cycloaddition (CuAAC, click chemistry) was developed to 
detect module-catalyzed polyketide formation (Chapter 4).  
Prasad and coworkers employed sulforhodamine B azide modified ACPs for the 
detection of KS specificity on a small library of monoketide-S-NAC substrates by 
CuAAC (Prasad, 2012). Inspired by this work, experiments were designed to monitor 
polyketide formation using terminal alkyne priming substrates, dialyzed EryMod6TE 
lysate and synthetic extender units. Polyketides were visualized upon CuAAC with 
fluorescent sulforhodamine B azide by HPLC (Figure 1-7). The utility of this method was 
demonstrated through experiments designed to investigate the reactivity of EryMod6TE 
to various substrates and reaction conditions. Results demonstrated that ethanethiol was 
found to be as effective as N-acetylcysteamine in delivering both priming units and 
extender units to PKS domains. Insights into the competing reactivities within 
EryMod6TE were revealed through triketide lactone products generated from a β-
 6 
ketoacyl ethanethioester substrate. The addition of phosphate increased enzymatic 
turnover, while the addition of glycerol resulted in thioesterase-mediated glycerolysis of 
priming units. 
Overall, our efforts focused on improving module-catalyzed polyketide yields and 
reducing costs for the preparative in vitro chemoenzymatic synthesis of polyketide 
compounds. Employing a promiscuous malonyl-CoA ligase enzyme allowed for the 
generation of diverse polyketide extender units by S. coelicolor MatB for the price of 
ATP. We demonstrated a high substrate tolerance of polyketide priming units by a PKS 
module, which lead to the module-catalyzed formation of 10 polyketide compounds. 
Lastly, a new method to follow terminal alkyne priming substrates through PKS module-
catalyzed reactions was developed in order to optimize reaction conditions and identify 
polyketide products that went previously undetected. The work described in the following 
chapters has helped scientific community advance towards procuring a PKS-generated 
library of stereochemically diverse molecules in vitro.  
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Figure 1-1 Target polyketide compounds for chemoenzymatic synthesis. 
Target complex natural products for preparative-scale chemoenzymatic synthesis include 
a) bryostatin, b) concanomycin, c) discodermolide and d) soraphen. 
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Figure 1-2 The erythromycin polyketide synthase (PKS). 
The erythromycin PKS is the most thoroughly studied of all PKSs. It is compromised of a 
loading didomain, which begins polyketide growth from a propionyl-CoA priming unit. 
The following six modules incorporate and process a (2S)-methylmalonyl-CoA extender 
unit. The polyketide is released from the PKS by the thioesterase (TE). It is then 
enzymatically decorated by tailoring enzymes to afford the biologically-active 
polyketide, Erythromycin A. KS – ketosynthase, AT – acyltransferase, KR – 
ketoreductase, DH – dehydratase, ER – enoylreductase, TE – thioesterase 
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Figure 1-3 Polyketide diversity through extender unit incorporation. 
The most common CoA-linked polyketide extender units are malonyl-CoA, (2S)-
methylmalonyl-CoA, and (2S)-ethylmalonyl-CoA; the most common ACP-linked 
polyketide extender units are (2R)-methoxymalonyl-ACP, (2R)-hydroxymalonyl-ACP, 
and (2S)-aminomalonyl-ACP. These extender units are incorporated into polyketides a) 
6-deoxyerythronolide B, b) amphotericin B aglycone, c) concanamycin A aglycone and 
d) a polyketide-nonribosomal peptide hybrid zwittermicin A.
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Figure 1-4 The six ketoreductase (KR) types. 
There are six KR types found within modular PKSs: A1, A2, B1, B2, C1 and C2. A-type 
KRs reduce the β-carbonyl to a L-hydroxy group, and B-type KRs reduce the β-carbonyl 
to a D-hydroxy group. C-type KRs lack the active site tyrosine residue and are reductase 
incompetent. Type 1 KRs are epimerase inactive and leave α-substituents in D-
configuration whereas type 2 KRs epimerize α-substituents to L-configuration. 
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Figure 1-5 NADPH regeneration from Bacillus subtilis glucose dehydrogenase. 
a) Schematic representation of the NADPH-regeneration system in which the reduction 
of NADP+ to NADPH is catalyzed by the oxidation of glucose to gluconolactone by 
Bacillus subtilis glucose dehydrogenase (GDH). b) Pymol image of GDH tetramer 
depicts GDH monomer (black cartoon) with bound glucose (yellow spheres) and NADP+ 
(green spheres) (PDB ID: 3ay6). 
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Figure 1-6 Triketide pyrone formation from EryMod6TE. 
a) Triketide pyrone compounds were enzymatically synthesized by EryMod6TE from 
MatB-generated methylmalonyl-S-NAC extender units and synthetic β-ketoacyl-S-NAC 
diketide priming units. b) Triketide pyrone compounds produced by modular “stuttering.” 
EryMod6TE was incubated with MatB-generated methylmalonyl-S-NAC extender units 
and synthetic acyl-S-NAC monoketide priming units. “Stuttering” refers to the 
phenomenon of a single module catalyzing more than one condensation reaction. 
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Figure 1-7 Polyketide detection method using fluorescent click chemistry. 
Terminal alkyne thioester substrates were incubated with EryMod6TE, synthetic 
methylmalonyl extender units and the NADPH regeneration system.  After 2 or 16 hours, 
polyketide products were visualized upon copper(I)-catalyzed azide alkyne cycloaddition 
(CuAAC) with sulforhodamine B azide and HPLC analysis. 
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Chapter 2 Enzymatic Extender Unit Generation for in vitro Polyketide 
Synthase Reactions: Structural and Function Showcasing of 
Streptomyces coelicolor MatB 
ABSTRACT 
In vitro experiments with modular polyketide synthases (PKSs) are often limited 
by the availability of polyketide extender units. To determine the polyketide extender 
units that can be biocatalytically accessed via promiscuous malonyl-CoA ligases, 
structural and functional studies were conducted on Streptomyces coelicolor MatB. We 
demonstrate that this adenylate-forming enzyme is capable of producing most CoA-
linked polyketide extender units as well as pantetheine- and N-acetylcysteamine-linked 
analogs useful for in vitro PKS studies. Two ternary product complex structures, one 
containing malonyl-CoA and AMP and the other containing (2R)-methylmalonyl-CoA 
and AMP, were solved to 1.45 Å and 1.43 Å resolution, respectively. MatB crystallized 
in the thioester-forming conformation, making extensive interactions with the bound 
extender unit products. This first structural characterization of an adenylate-forming 
enzyme that activates diacids reveals the molecular details for how malonate and its 
derivatives are accepted. The orientation of the α-methyl group of bound (2R)-
methylmalonyl-CoA, indicates that it is necessary to epimerize α-substituted extender 
units formed by MatB before they can be accepted by PKS acyltransferase domains. We 
demonstrate the in vitro incorporation of methylmalonyl groups ligated by MatB to CoA, 
pantetheine, or N-acetylcysteamine into a triketide pyrone by the terminal module of the 
6-deoxyerythronolide B synthase. Additionally, a means for quantitatively monitoring 
certain in vitro PKS reactions using MatB is presented. 
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INTRODUCTION 
To study the activities of PKS modules in vitro, a supply of polyketide extender 
units is necessary; however, the cost and availability of these molecules is prohibitive. If 
the extender units are obtained from a commercial source, experiments designed to 
produce over a milligram of polyketide product in vitro become impractical. An 
alternative is to use N-acetylcysteamine (NAC-)-linked extender units, which have been 
employed in feeding studies and in vitro reactions (Carroll, 2002; Pohl, 1998). Pohl et al. 
showed that on incubation of synthetic (2RS)-methylmalonyl-S-NAC with DEBS3, the 
third protein of the 6-deoxyerythronolide B synthase, in the presence of (2S, 3R)-3-
hydroxy-2-methylpentanoate-S-NAC and NADPH, the anticipated triketide lactone was 
generated (Pohl, 1998); this result indicates that the terminal DEBS3 AT accepts 
methylmalonyl units from (2S)-methylmalonyl-S-NAC. To access CoA-linked extender 
units enzymatically, Pohl and coworkers utilized the malonyl-CoA synthetase MatB from 
Rhizobium trifolii, which has a broad substrate tolerance, and demonstrated that it can 
produce malonyl-CoA, methylmalonyl-CoA, ethylmalonyl-CoA, as well as unnatural 
extender units such as cyclopropylmalonyl-CoA, cyclobutylmalonyl-CoA, 
benzylmalonyl-CoA, and cyclopropylmethylenemalonyl-CoA (Pohl, 2001). We have 
employed the previously uncharacterized Streptomyces coelicolor MatB to synthesize 
CoA-linked extender units and derivatives thereof.  
The S. coelicolor malonyl-CoA synthetase MatB is an adenylate-forming enzyme 
that is best classified with acyl-CoA synthetases. MatB is anticipated to be enzymatically 
and structurally homologous to such enzymes as acyl-CoA synthetases (Protein Data 
Bank [PDB] codes: 3EQ6, 1V26, 1PG3, 1RY2) (Kochan, 2009; Hisanaga, 2004; Gulick, 
2003; Jogl, 2004), 4-chlorobenzoyl-CoA ligase (PDB code: 1T5D) (Gulick, 2004), the 
adenylation domains (A-domains) of nonribosomal peptide synthetases (NRPSs; PDB 
 16 
codes: 3ITE, 3E7W, 1AMU) (Lee, 2010; Yonus, 2008; Conti, 1997; Strieker, 2010; 
Mootz, 2002; Marahiel, 2009), and firefly luciferase (PDB code: 2D1R) (Nakatsu, 2006). 
A structure of a diacid-activating adenylate-forming enzyme has not yet been reported. 
Reactions catalyzed by adenylate-forming enzymes can be represented by a medium-
chain acyl-CoA synthetase: in the adenylate-forming conformation a medium-sized fatty 
acid is selected to attack the α-phosphoryl moiety of adenosine triphosphate (ATP) via its 
carboxylate to yield an acyl-adenylate and pyrophosphate; in the thioester-forming 
conformation the thiol acceptor CoA is selected to perform the second half-reaction, 
generating acyl-CoA and AMP (Scheme 2-1) (Kochan, 2009).  
Here, we demonstrate the S. coelicolor MatB-catalyzed synthesis of polyketide 
extender units malonyl-CoA (mCoA), methylmalonyl-CoA (mmCoA), ethylmalonyl-
CoA (emCoA), methoxymalonyl-CoA (oxCoA), and hydroxymalonyl-CoA (hmCoA), 
marking the first enzymatic syntheses of oxCoA and hmCoA. Equivalent pantetheine- 
(PANT-) and NAC-linked extender units were also generated, demonstrating that MatB is 
not only promiscuous toward malonyl derivatives, but also thiol acceptors. Crystal 
structures of two MatB ternary product complexes were obtained with malonyl-CoA and 
AMP (1.45 Å resolution) and with (2R)-methylmalonyl-CoA and AMP (1.43 Å 
resolution). These are the first structures of a diacid-activating adenylate-forming 
enzyme. The strong electron density surrounding the protein, thioester product, and AMP 
provides some of the most complete snapshots of product formation in the enzyme 
superfamily. The orientation of the (2R)-methylmalonyl-CoA α-methyl group reveals the 
stereoselectivity of MatB toward α-substituted malonate derivatives and also reveals the 
pocket that enables MatB to be promiscuous toward α-substituents. In vitro reactions in 
which the methylmalonyl groups of MatB synthesized extender units mmCoA, 
mmPANT, and mm-S-NAC are incorporated into a triketide pyrone by the final module 
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of the 6-deoxyerythronolide B synthase exemplify the use of MatB. A protocol for 
monitoring such reactions through a coupled reaction, also catalyzed by MatB, is 
described.  
 
RESULTS 
MatB synthesizes diverse CoA-, PANT- and NAC-linked extender units 
Products from incubations of CoA and a diacid (malonic acid, methylmalonic 
acid, ethylmalonic acid, methoxymalonic acid, and tartronic acid) with MatB were 
collected during high-performance liquid chromatography (HPLC) runs and analyzed by 
mass spectrometry. The observed masses (calculated masses) from the hmCoA, oxCoA, 
mCoA, mmCoA, and emCoA reactions were 867.8(868.1), 881.9(882.1), 851.7(852.1), 
865.9(866.1), and 879.9(880.1), respectively, indicating the production of each of the five 
CoA-linked extender units (Figure 2-1a). Aminomalonyl-CoA could not be produced. 
MatB was also found capable of synthesizing PANT- and NAC-linked extender units; 
employing identical HPLC methanol gradients, the retention times of the PANT-linked 
extender units were increased relative to the CoA-linked extender units, whereas the 
retention times of the NAC-linked extender units were decreased (Figures 2-1b-c). Two 
product peaks were observed in each of the hmCoA, hmPANT, and hm-S-NAC reactions. 
Both peaks from the hm-S-NAC reaction were collected and subjected to LC/MS 
analysis. The observed masses (calculated masses) of 222.2(222.0) and 206.2(206.1) 
correspond to hm-S-NAC and m-S-NAC, respectively. The m-S-NAC peak may have 
resulted from a malonic acid impurity in the tartronic acid stock. With the addition of 
sufficient ATP, thiol, and diacid, MatB reactions can be scaled up to yield multimilligram 
quantities that can be readily analyzed by nuclear magnetic resonance (NMR). In 
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summary, S. coelicolor MatB produces each of the CoA-, PANT-, and NAC-linked 
extender units mCoA, mmCoA, emCoA, oxCoA, hmCoA, mPANT, mmPANT, 
emPANT, oxPANT, hmPANT, m-S-NAC, mm-S-NAC, em-S-NAC, ox-S-NAC, and hm-
S-NAC. 
Incorporation of MatB-synthesized mmCoA, mmPANT and mm-S-NAC into a 
triketide pyrone 
The final module and thioesterase from the 6-deoxyerythronolide B synthase 
(EryMod6TE) has been used in previous experiments to produce triketide lactones (Pohl, 
1998; Gokhale, 1999; Menzella, 2005). We were able to incorporate methylmalonate 
from MatB-synthesized mmCoA, mmPANT, and mm-S-NAC into a triketide pyrone by 
(1) incubating MatB ligation reactions overnight at 22 °C; (2) adding EryMod6TE, S. 
coelicolor methylmalonyl-CoA epimerase (Dayem, 2002), and (2S, 3R)-2-methyl-3-
oxopentanoate-S-NAC (Keatinge-Clay, 2007); and (3) incubating at least 16 hours at 22 
°C and analyzing for polyketide production via HPLC (Scheme 2-2, Figures 2-2a-b). To 
confirm the identity of the triketide pyrone, the fraction corresponding to the largest peak 
(at 290 nm) was collected and subjected to LC/MS; the observed mass (calculated mass) 
of the triketide pyrone was 169.2(169.1). In all reactions, mm-S-NAC is formed as a by-
product generated by MatB using methylmalonate and NAC liberated from (2S, 3R)-2-
methyl-3-oxopentanoate-S-NAC, although thioesterase-catalyzed hydrolysis of (2S, 3R)-
2-methyl-3-oxopentanoate-S-NAC may also contribute to mm-S-NAC formation (Figure 
2-2a) (Wang, 2009). Monitoring mm-S-NAC production represents a powerful, new 
method of following in vitro PKS reactions, especially those producing polyketides 
lacking chromophores. 
 19 
Overall MatB structure 
The conditions that yielded protein crystals contained all of the substrates 
required for the synthesis of mCoA or mmCoA as described in the Methods section. 
Briefly, purified protein was incubated with the substrates of the MatB reaction: ATP, 
magnesium, CoA, and malonate or methylmalonate. Clusters of elongated, orthorhombic 
crystals, often hollowed along their long axes, grew overnight. Diffraction data was 
collected using crystals flash-frozen in their mother liquor. Molecular replacement 
proved unsuccessful, as is often the case with adenylate-forming enzymes (Shah, 2009). 
The mCoA/AMP-bound MatB structure was solved via single-wavelength anomalous 
dispersion using selenomethionine-labeled protein. The native malonyl-CoA/AMP-bound 
and methylmalonyl-CoA/AMP-bound complexes were then refined at resolutions of 
1.45 Å and 1.43 Å, respectively (Table 2-1). A comparison of the ternary complexes 
yields root-mean-square deviation of 0.06 Å.  
MatB is comprised of 485 residues, possesses a molecular weight of 50.6 kDa, 
and is monomeric as determined through gel filtration chromatography and through an 
analysis of the packing within the crystals. Like other adenylate-forming enzymes, MatB 
has a large N-terminal body (residues 1–387) and a small C-terminal lid (residues 388–
485), yet is the smallest of the adenylate-forming enzymes solved to date (Figure 2-3a). 
No density was observed for the N-terminal histidine tag, residues 1–3, or residues 472–
485 of the C-terminal lid. No density for the 3′,5′-diphosphoadenosine of CoA was 
observed either, permitting only the phosphopantetheine moiety of CoA to be modeled. 
The overall structure for mCoA/AMP-bound MatB contains 467 residues, 348 waters, 1 
mCoA, 1 AMP molecule, and 1 solvated Mg2+ in the asymmetric unit. The overall 
structure of mmCoA/AMP-bound MatB contains 467 residues, 407 water molecules, 
1 mmCoA, 1 AMP molecule, and 1 solvated Mg2+ in the asymmetric unit. The electron 
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density clearly reveals an R stereochemistry at the α-carbon indicating that (2R)-mmCoA 
is bound. Other than the α-methyl group, the positions of the bound mCoA and (2R)-
mmCoA extender units are superimposable between the two structures.  
MatB observed in the thioester-forming conformation 
Adenylate-forming enzymes can adopt at least two catalytically distinct 
conformations (Reger, 2008; Kochan, 2009; Lee, 2010). The C-terminal lid pivots 140° 
between the two catalytically-active conformations (the adenylate-forming conformation 
and the thioester-forming conformation) in a process termed “domain alternation” 
(Reger, 2008; Shah, 2009) (Figure 2-3a). An aspartate located in a linker between the N-
terminal body and the C-terminal lid of adenylate-forming enzymes, is usually considered 
to be the principle pivot point about which the C-terminal lid rotates during domain 
alternation and is hypothesized to interact with the arginine that is the final residue of the 
N-terminal body in the thiolation conformation (Wu, 2008). The thioester-forming 
conformation of 4-chlorobenzoate-CoA ligase shows an ionic interaction between hinge 
residue D402 and the final residue of the N-terminal body (R400); the D402P and D402A 
mutants showed decreased catalytic activity (Reger, 2008; Wu, 2008). The putative hinge 
residue in MatB is D387, which is four residues after the final residue of the N-terminal 
body (R383) and highly conserved among malonyl-CoA synthetases. The side-chain 
electron density for the MatB linker (residues 384–388, KATDL) is too weak to observe 
interactions with R383. 
Comparison to adenylate-forming enzyme core motifs 
Highly conserved regions of adenylate-forming enzymes have been categorized 
into ten major core motifs (A1–A10, Table 2-2) (Marahiel, 1997). Motif A3 contains a 
serine/threonine-rich region hypothesized to interact with the β- and γ-phosphates of 
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ATP during the adenylation reaction, stabilizing the release of pyrophosphate; S. 
coelicolor MatB contains an equivalent region (Marahiel, 1997). The role of motifs A4 
and A5 are to bind the carboxylate substrate and stabilize the formation of the adenylate 
intermediate; ten residues, mostly located between these motifs, have been identified as 
“specificity-conferring residues” that form the binding site for a carboxylate substrate 
(Stachelhaus, 1999). A conserved aspartate in motif A4 of A-domains (FDXS) ionically 
interacts with the α-amino group of bound amino acids; in S. coelicolor MatB, the 
corresponding residue is V188 (HVHG) (PDB codes: 1AMU and 3E7W) (Conti, 
1997; Yonus, 2008). H189, also within S. coelicolor MatB motif A4, coordinates with the 
specificity-conferring residues S261 and R238 to help form the malonate binding pocket. 
Within the S. coelicolor MatB motif A5 (ERYGMTE), R238 forms a salt bridge with the 
extender unit carboxylate in each of the ternary product complex structures; the 
corresponding residue in the phenylalanine-selective A-domain of the gramicidin 
synthetase is A322 (NAYGPTE), which helps create a large hydrophobic pocket for the 
phenylalanine side chain (PDB code: 1AMU) (Conti, 1997). Interestingly, the loop 
immediately following motif A5, which contains two specificity-conferring residues, is 
one residue shorter in S. coelicolor MatB than in most adenylate-forming enzymes. Thus, 
the position of the specificity-determining residue M291 in S. coelicolor MatB is slightly 
different than the most equivalent residue, C331, in the phenylalanine-activating A-
domain of the gramicidin synthetase. In terms of length and orientation, the loop 
following motif A5 that is most similar to that of S. coelicolor MatB is from a medium-
chain adenylate-forming enzyme (PDB code: 3EQ6) (Kochan, 2009). 
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Bound malonyl-CoA and methylmalonyl-CoA 
Both mCoA and (2R)-mmCoA products are bound between the N-terminal body 
and C-terminal lid of MatB. Although a few adenylate-forming enzymes have been 
solved with CoA or thioester products bound (PDB codes: 2P2F, 1PG4, 3EQ6) (Reger, 
2007; Gulick, 2003; Kochan, 2009), the MatB complex structures presented here provide 
the strongest density for a phosphopantetheinyl arm to date. In both structures, the bound 
extender unit displays electron density that continues past the CoA β-phosphoryl moiety 
and possesses an average B-factor lower than the average B-factor of MatB. The 
interactions with the extender unit products can be divided into three categories: 
 
1. Malonyl groups are bound primarily by residues S261 and R283 (Figure 2-3d). 
The presence of the arginine in core motif A5 is a hallmark of malonyl-CoA 
synthetases. Indeed, R283 serves an important functional role: the ternary 
complexes reveal that it forms strong ionic interactions with the carboxylates of 
both mCoA and mmCoA (another active site arginine forms strong ionic 
interactions with this carboxylate in ATs when the extender unit is selected for 
transfer to an ACP [Tang 2006]). The observed ψ and ϕ angles for S261 are 
−17.9 ° and 88.5 °, respectively; that these values are outside of the expected 
Ramachandran regions suggests the importance of S261 in the MatB reaction 
(Herzberg, 1991). In the ternary complexes presented in this work, S261 
participates in a hydrogen-bonding network that includes R283 and the extender 
unit carboxylate (Figure 2-3d).  
 
2.   The pantetheine arm is contacted by hydrogen bonds from the backbone 
carbonyls of residues G392 and G393 as well as hydrophobic interactions 
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principally mediated by Y384 (as observed in a medium-chain acyl-CoA 
synthetase ternary complex, PDB code: 3EQ6) (Figure 2-3e) (Kochan, 2009). The 
A8 core motif, which contains these residues, is hypothesized to possess multiple 
functions: in the adenylate-forming conformation, the first arginine may help 
stabilize the pyrophosphate leaving group; in the thioester-forming conformation, 
it may interact with the pantetheinyl arm, as observed in the MatB structure. 
 
3.  The CoA β-phosphate is ionically bound by R236 and R461 (Figure 2-3f). A third 
arginine, R459, may form ionically interact with the CoA α-phosphate as it is 
within 6 Å. 
Bound adenosine monophosphate 
AMP is bound in the MatB ternary complex structures at a site equivalent to that 
observed in other adenylate-forming enzymes (e.g., PDB codes: 3EQ6, 1MD9, 3E7W, 
1AMU, 2P2F, 3FCC). The 2Fo-Fc electron density maps (contoured at σ = 1.6) do not 
completely surround AMP; however, the overall B-factors for AMP in the mCoA- and 
mmCoA-bound MatB structures are 22 Å2 and 23 Å2, respectively, which is only slightly 
higher than the average B-factors for the MatB residues (16.6 Å2 and 17.3 Å2, 
respectively) (Figure 2-4b). The distance from the thioester carbon to the nearest oxygen 
atom of the AMP phosphate, which had been covalently bonded to one another in the 
adenylate intermediate, is ∼3.6 Å. Positively-charged K390 and K395 form ionic 
interactions with the AMP α-phosphate, whereas T287 also forms a hydrogen bond with 
it (Figure 2-4e). The backbone carbonyl of R283 forms a hydrogen bond to the N7-amine 
of adenine, while a conserved aspartic acid, D368, interacts with both AMP hydroxyl 
groups (Figure 2-4c).   
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DISCUSSION 
Malonyl-CoA synthetases are capable of generating many extender units for 
in vitro PKS reactions. R. trifolii MatB is frequently used to generate malonyl-CoA for 
PKSs that utilize α-unsubstituted extender units (Gao, 2010). Here, we have 
demonstrated that S. coelicolor MatB, like R. trifolii MatB, ligates diverse malonate 
derivatives to CoA to generate a diversity of α-substituted polyketide extender units that 
are utilized by modular PKSs. We have shown that S. coelicolor MatB is also 
promiscuous toward thiol acceptors, as established by the synthesis of PANT- and NAC-
linked extender units. These extender units are nearly as efficient as CoA-linked extender 
units at transferring malonate derivatives to PKS modules, as demonstrated by our 
experiments using EryMod6TE in the production of a triketide pyrone (Figure 2-2b). 
In an effort to understand the nature of the promiscuity of MatB toward malonate 
derivatives and thiol acceptors, as well as the stereoselectivity imposed by MatB toward 
α-substituted malonate derivatives, the structures of two MatB ternary product complexes 
were obtained. These structures, combined with information from analyses of more 
thoroughly studied adenylate-forming enzymes, allow the following catalytic cycle to be 
proposed for MatB-catalyzed synthesis of malonyl-CoA: malonate and ATP bind to 
MatB, with the binding of ATP potentially causing the C-terminal lid to dock to the N-
terminal body in the adenylate-forming conformation (Kochan, 2009). Malonate binds 
largely via a salt-bridge between one of its carboxylates and R283 and S261 (Figure 2-
3d). By analogy with other adenylate-forming enzymes, MatB interacts with ATP by 
bonding to its phosphates with the serine/threonine-rich A3 core motif, its ribose with the 
conserved aspartate D368, and its adenine through van der Waals interactions with loop 
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residues S261–A263 (Figures 2-4c-e). The free carboxylate of the malonate is positioned 
to attack the ATP α-phosphate, releasing pyrophosphate, which may be stabilized as a 
leaving group by K476 (Kochan, 2009). After pyrophosphate diffuses from the active 
site, the C-terminal lid pivots about D387 to adopt the thioester-forming conformation in 
which the “pantetheine tunnel” is created. The malonyl-adenylate remains bound during 
this domain alternation process. CoA then binds through hydrogen bonds with the G392 
and G393 carbonyls, hydrophobic interactions with Y394, and ionic interactions with 
R236 and R461 (Figures 2-3e-f). Inspection of the MatB structures does not reveal a site 
that recognizes the 3′,5′- diphosphoadenosine of CoA as is observed other adenylate-
forming enzymes (e.g., PDB codes: 1PG3 and 2P2F). The entry of CoA into the MatB 
active site is halted when the diphosphate moiety forms salt-bridges with positively 
charged residues at the tunnel opening (Figure 2-3f), although these ionic interactions are 
not required for catalysis because PANT and NAC can serve as thiol acceptors. Because 
the pantetheinyl arm makes as many contacts to the C-terminal lid as it does with the N-
terminal body, CoA likely enters the pantetheine tunnel after tunnel formation. After an 
attack of the CoA thiolate on the malonyl-adenylate carbonyl, the leaving group AMP, 
stabilized by K395, is generated. Finally, AMP and the malonyl-CoA extender unit 
diffuse out of the active site, aided by the pivoting motion of the C-terminal lid during 
domain alternation. 
The 2Fo-Fc electron density maps from the mmCoA/AMP-bound MatB ternary 
complex suggest that MatB forms (2R)-mmCoA and not (2S)-mmCoA. In related 
structures, the position of a bound AMP is similar to its position within the adenylate 
intermediate, thus this intermediate can be approximately reconstructed from the 
positions of the malonyl group and AMP (Reger, 2007; Reger, 2008; Conti, 1997; Yonus, 
2008; Hisanaga, 2004; Kochan, 2009). Due to the proximity of the α-substituent and the 
 26 
AMP phosphoryl moiety (∼4 Å in the ternary product complex and likely closer within 
the adenylate intermediate), the stereochemistry of the α-carbon is limited to the R-
configuration (Figure 2-5c). The formation of (2R)-mmCoA is consistent with 
observations from previous experiments that failed to synthesize polyketides from 
mmCoA produced by MatB in the absence of an epimerase (Murli, 2003). Thus, we 
hypothesize that MatB also synthesizes (2R)-emCoA, (2R)-hmCoA, and (2R)-oxCoA in a 
stereocontrolled manner. As the AT domains of PKSs are very stereoselective, only 
accepting (2S)-mmCoA and (2S)-emCoA, epimerization of mmCoA and emCoA is 
necessary for the incorporation of these MatB-synthesized extender units into PKSs and 
can be accomplished via spontaneous epimerization under acidic conditions or 
enzymatically-catalyzed epimerization through the addition of an epimerase (e.g., 
mmCoA epimerase) (Murli, 2003). 
Organic syntheses of mSNAC, mmSNAC, oxSNAC, and hmSNAC have been 
reported (Pohl, 1998; Carroll, 2002); however, the syntheses of hmSNAC and oxSNAC 
involve multistep syntheses with 13% and 29% yields, respectively (Carroll, 2002). 
Using MatB, super-stoichiometric quantities of extender units can be enzymatically 
produced in situ to drive the synthesis of milligram quantities of polyketides from in vitro 
reactions. MatB also serves as an extender unit regeneration system, as supported by the 
formation of mm-S-NAC in the Mod6TE reactions. With the addition of excess diacid 
and ATP, MatB will continually regenerate product by recycling the appropriate thiol 
acceptor (e.g., CoA, PANT, or SNAC). The MatB-catalyzed formation of α-substituted 
extender units enables the generation of otherwise unavailable isotopically- or 
radioactively-labeled extender units for more detailed in vitro PKS studies. The 
generation of hmCoA and oxCoA also suggests the potential of genetically engineering 
PKSs to produce sugar derivatives. 
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The hydrophobic residues V188 and M291 adjacent to the α-methyl group of 
(2R)-mmCoA, as observed in the mmCoA/AMP/MatB ternary complex, likely influence 
the promiscuity of MatB for α-substituted malonate derivatives and may explain why S. 
coelicolor MatB was unable to synthesize aminomalonyl-CoA. Within A-domains, an 
aspartate is usually positioned in the A4 core motif to ionically interact with the amino 
group of a selected amino acid; within MatB, this position is occupied by V188. The 
chemical incompatibility of a valine side chain with a charged amino group may preclude 
the formation of aminomalonyl-CoA. A structural alignment of MatB with a D-
alanine:D-alanyl carrier protein ligase (PDB code: 3E7W) suggests that the MatB mutant 
V144D would bind aminomalonate and catalyze the formation of aminomalonyl-CoA 
(Figures 2-5a-b). We have not tested for the formation of the less commonly utilized 
extender units propylmalonyl-CoA or chloroethylmalonyl-CoA; however, if MatB is not 
capable of selecting the corresponding diacids, appropriate mutagenesis of V188 and 
M291 may enable the formation of these extender units. 
Thus, an enzymatic means to produce CoA-, PANT-, and NAC-linked polyketide 
extender units is provided. This reaction may be utilized by many PKS laboratories to 
produce significant quantities of extender units, especially when they are economically 
unviable or commercially unavailable. The utility of MatB for in vitro PKS reactions was 
demonstrated not only through the incorporation of the methylmalonyl groups of 
mmCoA, mmPANT, and mm-S-NAC by a PKS module to form a polyketide product but 
also through the ability to observe reaction progress by monitoring the production of the 
coupled product, mm-S-NAC. The MatB ternary product complexes have provided 
chemical insights into the malonyl-CoA synthetase reaction as well as structural insights 
into substrate promiscuity. Efforts to alter the stereochemistry of α-substituted extender 
unit products will most likely not be successful due to the hypothesized geometry of the 
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adenylate intermediate; however, the range of the sizes and chemistries of α-substituents 
of malonate derivatives ligated by MatB is quite large, and apparently only limited by the 
nearby residues V188 and M291. 
 
MATERIALS AND METHODS 
Synthesis of compounds utilized 
N-acetylcysteamine (NAC) 
Cysteamine hydrochloride (1.14 g, 10.0 mmol, 1.0 eq.), KOH (0.56 g, 10.0 mmol, 
1.0 eq.), and NaHCO3 (2.52 g, 30.0 mmol, 3.0 eq) was dissolved in a round-bottom flask 
containing 50 ml water. After the dropwise addition of acetic anhydride (0.95 mL, 
10.0 mmol, 1.0 eq.), the solution was stirred at 22°C for 10 minutes. The pH was then 
adjusted to 7.3 using 12.1 N HCl. The resulting mixture was extracted with ethyl acetate 
(50 mL x 3). The organic layer was dried using MgSO4, and after filtration a quantitative 
yield of N-acetylcysteamine was isolated in vacuo.  
 N-acetylcysteamine (NAC) 1H-NMR (CDCl3) 400 MHz, δ (ppm): 5.97 (1H, bs), 
3.40 (2H, q, J = 8.0), 2.65 (2H, m, J = 8.4), 1.98 (3H, s), 1.33 (1H, t, J = 8.8). 
Methoxymalonic acid 
Dimethyl methoxymalonate (0.85 mL, 6.2 mmol, 1.0 eq.) and NaOH (2.4 g, 
60 mmol, 9.7 eq.) was dissolved in a round-bottom flask containing 10 mL water. The 
resulting solution was stirred at 65°C overnight. The solution was then acidified with 
10 mL 12.1 N HCl and extracted with ethyl acetate (30 mL x 3). The organic layer was 
dried using MgSO4, and after filtration a quantitative yield of methoxymalonic acid was 
isolated in vacuo. 
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D-pantetheine 
D-pantethine (0.021 mmol, 1.0 eq.) and DTT (0.022 mmol, 1.0 eq.) were 
dissolved in 100 μl 20% (w/v) glycerol (aq.). The solution was incubated at 60°C for 15 
minutes, and the resulting D-pantetheine solution was stored at 22°C. 
Cloning 
The matB gene was amplified from S. coelicolor genomic DNA using primers 5′-
TCGATTGCACATATGTCCTCTCTCTTCCCGGCCCTCT-3′ and 5′-
ATCGGATAGCTCGAGTCAGTCACGGTTCAGCGCCCGCTT-3′. The gene encoding 
methylmalonyl-CoA epimerase was amplified from S. coelicolor genomic DNA using 
primers 5′-ATCCCGAATCATATGCTGACGCGAATCGACCA-3′ and 5′-
TTAGTCTGGCTCGAGTCAGTGCTCAGGTGACTCAA-3′. Fragments were digested 
with NdeI and XhoI (italicized) and ligated into pET28b plasmid between the 
corresponding restriction sites. Plasmid design allowed for the incorporation of a stop 
codon (underlined) at the 3′ terminus of the DNA encoding both MatB and 
methylmalonyl-CoA epimerase. Synthetic DNA encoding the N-terminal docking 
domain from DEBS3 fused to the sixth module and thioesterase from DEBS3 was a gift 
from Kosan Biosciences (Menzella, 2005). The DNA was digested at the flanking NdeI 
and EcoRI restriction sites and ligated into pET28b. 
Protein expression and purification 
MatB and methylmalonyl-CoA epimerase expression plasmids were transformed 
into Escherichia coli BL21(DE3), whereas the EryMod6TE expression vector was 
transformed into E. coli K207-3 cells (Murli, 2003). Starter cultures (50 ml) were grown 
overnight and used to inoculate prewarmed (37°C) Luria broth, supplemented with 
50 mg/L kanamycin. When OD600 = 0.4, the media was cooled (15°C) and protein 
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expression was induced with 0.5 mM IPTG. After 16 hr, cells were harvested by 
centrifugation, resuspended in lysis buffer (10% glycerol, 0.5 M NaCl, 100 mM HEPES 
pH 7.5), sonicated, and centrifuged (30,000 relative centrifugal force for 45 min) to 
remove cellular debris. Cell-free lysate was passed over a nickel-NTA column 
equilibrated with lysis buffer. The column was washed with lysis buffer containing 
15 mM imidazole and protein was eluted using lysis buffer containing 150 mM 
imidazole. Final protein concentrations were determined using a Thermo Scientific 
Nanodrop 1000. 
MatB was further purified for crystallization via gel filtration using a Superdex 
200 column equilibrated in gel filtration buffer (10% glycerol, 150 mM NaCl, and 
10 mM HEPES pH 7.5). By comparison to a gel filtration standard (Bio-Rad), MatB 
eluted as a ∼50 kDa monomer. Fractions were collected and concentrated to 15 mg/ml in 
gel filtration buffer (Millipore Centrifugal Filter Unit, 30 kDa MWCO). The final protein 
concentration was determined by using a Thermo Scientific Nanodrop 1000. 
The same purification protocol was followed for selenomethionine-labeled MatB 
(Se-MatB); however, growth and expression conditions differed. Each liter of M9 growth 
medium contained 6 g Na2HPO4, 3 g KH2PO4, 500 mg NaCl, 1 g NH4Cl, 0.1 mM CaCl2, 
1 mM MgSO4, 0.4% glucose, and 20 mg kanamycin. Prewarmed (37°C) media was 
inoculated with saturated starter culture (3 ml). When the OD600 = 0.4, each liter of media 
was supplemented with lysine, phenylalanine, and threonine (each 100 mg), isoleucine, 
leucine, and valine (each 50 mg), and selenomethionine (60 mg). After 15 min protein 
expression was induced with 0.5 mM IPTG. The cultures were then cooled (15°C) and 
after 16 hr cells were harvested. Protein purification, gel filtration, and concentration of 
Se-MatB protein followed the methods described above. 
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Protein crystallization 
The following conditions were used for the protein solution of mmCoA/AMP-
bound selenomethionine-labeled MatB: 15.8 mg/ml Se-MatB, 1 mM CoA, 5 mM 
methylmalonate pH 7.5, 1 mM ATP, 2 mM DTT, and 5 mM MgCl2. Optimal 
mmCoA/AMP-bound selenomethionine-labeled MatB crystals grew overnight in 31% 
PEG 4000, 100 mM MgCl2, and 100 mM Tris-HCl pH 7.5 via sitting drop vapor 
diffusion at 22°C with a protein solution to crystallization buffer ratio of 1:1. The 
following conditions were used for the protein solution of mCoA/AMP-bound MatB: 
10 mg/ml MatB, 20 mM CoA, 24 mM sodium malonate pH 7.7, 24 mM ATP, and 
48 mM MgCl2. Optimal mCoA/AMP-bound MatB crystals grew overnight in 35% PEG 
4000, 100 mM MgCl2, and 100 mM Tris-HCl pH 8.2 via sitting drop vapor diffusion at 
22°C with a protein solution to crystallization buffer ratio of 1:1. The following 
conditions were used for the protein solution of mmCoA/AMP-bound MatB: 9.6 mg/ml 
MatB, 20 mM CoA, 24 mM sodium methylmalonate pH 7.5, 24 mM ATP, and 48 mM 
MgCl2. Optimal mmCoA/AMP-bound MatB crystals were grown overnight in 33% PEG 
4000, 100 mM MgCl2, and 100 mM Tris-HCl pH 9.5 via sitting drop vapor diffusion at 
22°C with a protein solution to crystallization buffer ratio of 1:1. 
Data collection, processing and refinement 
Diffraction data were collected at ALS beamline 5.0.2, then integrated and scaled 
using HKL2000 (Otwinowski, 1997). The structure of mmCoA/AMP-bound 
selenomethionine-labeled MatB was solved by single-wavelength anomalous dispersion 
using Phenix (Adams, 2002). This structure was used as a search model for molecular 
replacement using Phaser (CCP4, 1994), yielding the solutions for both mCoA/AMP-
bound MatB and mmCoA/AMP-bound MatB. Water molecules were identified using 
Coot (Fo-Fc map contoured at σ = 3.0) (Emsley, 2004). Refinement cycles using Coot 
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(Emsley, 2004) and Refmac5 (CCP4, 1994) were performed until the R-factors could no 
longer be improved (Table 2-1). Figures were prepared using PyMol (DeLano, 2002) and 
LIGPLOT (Wallace, 1995). 
HPLC analysis of MatB reactions 
Enzymatic reactions to generate extender units were set up using the following 
conditions: 6 nM MatB, 0.55 mM CoA or 1.0 mM D-pantetheine or 4.2 mM NAC, 
1.3 mM ATP, 22 mM malonate derivative, 9 mM MgCl2, 15% (w/v) glycerol, and 
100 mM HEPES pH 7.5. All reactions were incubated at 22°C overnight. Samples were 
analyzed by HPLC (Waters) using a Varian Microsorb-MV 300-5 C18 column and a 
Waters 2998 photodiode array detector. The mobile phases consisted of water containing 
0.1% TFA (solvent A) and methanol containing 0.1% TFA (solvent B). A linear gradient 
(flow rate = 1 ml/min) of 0%–67% B over 20 minutes was used for sample analysis. 
Reactions were monitored at 254 nm (adenine, CoA) or 235 nm (thioester bond, NAC, 
and PANT compounds). 
HPLC analysis of triketide pyrone reactions 
MatB reactions were set up using the following conditions: 5 mM CoA or 5 mM 
D-pantetheine or 5 mM NAC, 100 mM HEPES pH 7.5, 100 mM MgCl2, 20 mM ATP (in 
100 mM HEPES pH 7.5), 50 mM sodium methylmalonate pH 7.2, 10% glycerol, and 8 
nM MatB. Reactions were incubated at 22°C overnight and analyzed by HPLC to ensure 
formation of mmCoA, mmPANT, or mm-S-NAC. EryMod6TE reactions were set up by 
adding (2S, 3R)-2-methyl-3-oxopentanoate-S-NAC (diketide-S-NAC) (10 mM, final), S. 
coelicolor methylmalonyl-CoA epimerase (12 nM, final), and EryMod6TE (4 nM, final) 
to the MatB reaction, resulting in a 2-fold dilution of the MatB reaction. Reactions were 
incubated at 22°C for 16 hours. Samples were analyzed by HPLC (Waters) using a 
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Varian Microsorb-MV 300-5 C18 column and a Waters 2998 photodiode array detector. 
The mobile phases consisted of water containing 0.1% TFA (solvent A) and methanol 
containing 0.1% TFA (solvent B). A linear gradient (flow rate = 1 ml/min) of 0%–100% 
B over 15 minutes was used. Reactions were monitored at 254 nm (adenine, CoA), 
235 nm (thioester bond, NAC, and PANT compounds), and 290 nm (triketide pyrone). 
Mass spectrometry analysis 
CoA-linked extender units were collected from HPLC runs and isolated in vacuo. 
Samples were subjected to low-resolution negative-ESI mass spectrometry performed 
with a Finnigan LCQ ion trap mass spectrometer with the needle voltage set to 3 kV and 
the capillary temperature set to 120°C. 
LC/MS analysis 
The triketide pyrone and two products from the hm-S-NAC reaction were 
collected, isolated in vacuo, resuspended in 25% acetonitrile and 0.1% formic acid, and 
subjected to positive-ESI LC/MS (Agilent Technologies 1200 Series HPLC with a 
Gemini C18 column coupled to an Agilent Technologies 6130 quadrupole mass 
spectrometer). Mobile phases consisted of water containing 0.1% formic acid (solvent A) 
and acetonitrile containing 0.1% formic acid (solvent B). A linear gradient (flow rate = 
0.7 ml/min) of 5%–95% B over 12 minutes was used. 
Accession numbers 
Coordinates were deposited with PDB Codes 3NYR and 3NYQ for mCoA/AMP-
bound and (2R)-mmCoA/AMP-bound MatB, respectively. 
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Scheme 2-1 MatB reaction mechanism. 
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Figure 2-1 HPLC analysis of MatB reactions. 
(a–c) MatB synthesized 15 polyketide extender units valuable for in vitro PKS reactions. 
Retention times (min) of extender units formed using CoA, PANT, and NAC as the thiol 
acceptor are indicated. The observed masses (calculated masses) from the hmCoA, 
oxCoA, mCoA, mmCoA, and emCoA reactions were 867.8(868.1), 881.9(882.1), 
851.7(852.1), 865.9(866.1), and 879.9(880.1), respectively. The two peaks observed for 
hm-S-NAC at 6.24 and 8.97 min were analyzed by positive-ESI LC/MS and correspond 
to hm-S-NAC (222.2(222.0)) and m-S-NAC (206.2(206.1)); the presence of m-S-NAC is 
may be from a malonate impurity in the tartronic acid stock. Colors indicated bound 
products: green – hydroxymalonyl-; red – methoxymalonyl-; black – malonyl-; orange – 
methylmalonyl-; blue - ethylmalnoyl-; *AMP.  
 36 
 
 
Scheme 2-2 Enzymatic synthesis of triketide pyrone by EryMod6TE. 
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Figure 2-2 HPLC analysis of the formation of triketide pyrones. 
a) HPLC analysis of Mod6TE reactions at 235 nm. The formation of mm-S-NAC (from 
the transthioesterification of diketide-S-NAC) may be used as a diagnostic tool to follow 
an in vitro PKS reaction. b) HPLC analysis of Mod6TE reactions at 290 nm. Triketide 
pyrone was synthesized from all three different extender units, (2S)-
mmCoA/PANT/NAC. The identity of triketide pyrone was confirmed by positive-ESI 
LC/MS with an observed mass (calculated mass) of 169.2(169.1). 
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Table 2-1 Data collection and refinement of S. coelicolor MatB structures.   
 
MatB  
(mCoA) 
3NYR 
MatB 
(2R-mmCoA) 
3NYQ 
SeMatB 
(2R-mmCoA) 
Space Group C222(1) C222(1) C222(1) 
Cell dimensions    
     a, b, c (Å) 73.2, 86.6, 153.1 
73.4, 86.8, 
153.4 73.9, 87.4, 154.4 
     a = β = g (°) 90 90 90 
     Resolution (Å) 50-1.45 50-1.43 50-1.75 
     Rmerge 0.051 (0.439) 0.062 (0.292) 0.080 (0.202) 
     I/σ(I) 23.1 (2.6) 15.5 (3.9) 30.8 (7.1) 
     Completeness (%) 99.8 (99.4) 98.5 (82.4) 97.8 (94.7) 
     Redundancy 7.1 (4.5) 6.8 (3.8) 3.9 (4.0) 
Refinement    
     Resolution (Å) 50-1.45 50-1.43 50-1.75 
     Unique reflections 621,987 671,166 537,849 
     Rwork/Rfree 0.1997/0.2247 0.1951/0.2161 0.2026/0.2353 
     Ramachandran  
     Allowed(Outlier)(%) 99.34(0.66) 99.34(0.66) 99.55(0.45) 
Number of Atom    
     Protein 3378 3378 3320 
     Extender unit 28 29 29 
     AMP 23 23 N/A 
     Water 347 404 338 
B factors (Å2)    
     Protein 16.72 17.40 19.66 
     Extender unit 14.60 14.29 21.06 
     AMP 21.94 23.79 N/A 
     Water 26.50 27.64 27.75 
Rmsd    
Bond lengths (Å) 0.010 0.013 0.011 
Bond angles (°) 1.80 1.77 1.45 
Highest Res. Bin (Å) 1.49-1.45 1.47-1.43 1.78-1.75 
AMP: Adenosine monophosphate; RMSD: root-mean-square deviations 
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Figure 2-3 Ternary complex MatB structure reveals bound product. 
a) Overall structure of the mmCoA/AMP/MatB ternary complex. N-terminal body (light 
blue), C-terminal lid (dark blue) and (2R)-mmCoA and AMP (green). b) LIGPLOT 
representation of interactions observed between (2R)-mmCoA and surrounding MatB 
residues. c) Simulated-annealing omit map of (2R)-mmCoA (contoured at σ = 3.0). d) 
H189, S261, and R283, interact with methylmalonyl moiety of (2R)-mmCoA. A 
hydrogen-bonding network is formed between S261, R283, and the (2R)-mmCoA 
carboxylate (distances in Å, 2Fo-Fc map contoured at σ = 1.6). e) Carbonyls from G392 
and G393 hydrogen bond with the pantetheine amide groups (distances in Å, 2Fo-Fc map 
contoured at σ = 1.6). f) R236 and R461 form salt-bridges with the (2R)-mmCoA β-
phosphate. No density was observed for the 30,50-diphosphoadenosine; however, the 
positively charged pantetheine tunnel entrance likely interacts with both α- and β-
phosphate groups (distances in Å, 2Fo-Fc map contoured at σ = 1.6). g) V188 and M291 
form a hydrophobic pocket near the α-methyl substituent of (2R)-mmCoA (distances in 
Å, 2Fo-Fc map contoured at σ = 1.6). 
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Table 2-2 Core motifs conserved in adenylate-forming enzymes. 
AMP: adenosine monophosphate; ATP: adenosine triphosphate 
 
 
 
Core Function 
Adenylate-Forming 
Enzyme  
Consensus Sequence 
Corresponding MatB 
Sequence 
A1 Structural L(TS)YxEL (29)LTYAEL(34) 
A2 Structural LKAGxAYL(VL)P(LI)D (69)LLAGVAAVPLN(79) 
A3 
Stabilize 
pyrophosphate 
leaving group 
LAYxxYTSG(ST)TGxPKG (137)PALVVYTSGTT- GPPKG(152) 
A4 
Asp interacts with 
α-amino groups of 
peptides  
FDxS (187)HVHG(190) 
A5 Stabilize product NxYGPTE (282)ERYGMTE(288) 
A6 Unknown GELxIxGxG(VL)ARGYL (334)GEIQVRGPNLFT- EYL(348) 
A7 Stabilize ATP/AMP ribose  Y(RK)TGDL (364)FRTGDM(369) 
A8 Essential for adenylation 
GRxDxQVKIRGxRIELGEI
E 
(382)GRKATDLIKSGGY-
KIGAGEIE(402) 
A9 Unknown LPxYM(IV)P (454)LAPHKRP(460) 
A10 Stabilize ATP/AMP ribose NGK(VL)DR (474)MGKIMK(479) 
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Figure 2-4 Ternary complex MatB structure reveals AMP leaving group bound. 
a) LIGPLOT diagram of AMP and MatB interactions (distances in Å). b) Simulated-
annealing omit map of AMP (contoured at σ = 3.0). c) Interaction between conserved 
D368 and hydroxyl groups of AMP (2Fo-Fc map contoured at σ = 1.6). d) 2Fo-Fc electron 
density map surrounding AMP (contoured at σ = 1.6). e) Ionic interactions between the 
AMP α-phosphate and both K390 and K395. The backbone amide and hydroxyl group of 
T287 form hydrogen bonds with the AMP α-phosphate (distances in Å, 2Fo-Fc map 
contoured at σ = 1.6). f ) Stereodiagram of (2R)-mmCoA and AMP within the active site 
(distances in Å, 2Fo-Fc map contoured at σ = 1.6). 
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Figure 2-5 Engineering MatB substrate specificity and product stereochemistry. 
a) Structural alignment of MatB (blues) and DltA (greys, PDB code: 3E7W). DltA is an 
A-domain that ligates D-alanine onto the phosphopantheinyl arm of a peptidyl carrier 
protein. b) D196 (gray) of the FDxS motif in DltA ionically interacts with the of D-
alanine amino group. The MatB mutant V188D could catalyze the formation of 
aminomalonyl-CoA. c) The distance between the AMP leaving group and the α-carbon is 
3.91Å. Re-engineering MatB to form (2S)-α-substituted extender units may not be 
possible because the α-substituent of a (2S)-α-substitued-malonyl adenylate intermediate 
would clash with the AMP phosphoryl moiety. MatB is hypothesized to synthesize (2R)-
mmCoA, (2R)-emCoA, (2R)-hmCoA, and (2R)-oxCoA (2Fo-Fc map contoured at σ = 
1.6). 
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Chapter 3 Employing a Polyketide Synthase Module and Thioesterase 
in the Semipreparative Biocatalysis of Diverse Triketide Pyrones 
ABSTRACT 
To demonstrate the potential of polyketide synthase (PKS) modules as 
biocatalysts that can synthesize polyketides in vitro, the terminal module and thioesterase 
(TE) from the erythromycin PKS were employed in the multimilligram, chemoenzymatic 
syntheses of diverse triketide pyrones. Methylmalonyl-S-NAC extender units were 
generated by the promiscuous malonyl-CoA ligase Streptomyces coelicolor MatB. 
Initiating the reaction with β-ketoacyl-N-acetylcysteamine thioester diketides yielded the 
anticipated triketide pyrones through chain extension and cyclization. TE-mediated 
hydrolysis of the substrates prevented quantitative yields; however, a reaction with 200 
mg of diketide substrate generated 20 mg of pyrone product. Trace quantities of a 
particular pyrone were observed in all reactions and was hypothesized to result from 
extender unit decarboxylation and subsequent ‘‘stuttering’’. To harness this polymerase-
like activity, reactions were initiated with diverse acyl-N-acetylcysteamine thioester 
compounds to yield the anticipated triketide pyrones, one harboring a terminal alkyne 
chemical handle. This biocatalytic system enables more informative analysis of in vitro 
PKS reactions by HPLC, NMR, and crystallography and sets the stage for the preparative 
generation of polyketides such as chiral building blocks valuable in the synthesis of 
natural products and pharmaceuticals. 
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INTRODUCTION 
Trace quantities of triketide products have been generated, often from 
radiolabeled extender units, in enzymology studies of PKS modules fused to TEs 
(ModTEs). Larger quantities of triketide products have been generated by feeding 
diketide substrates to bacteria expressing ModTEs (Regentin, 2004). Here we show that 
the terminal module and TE of the erythromycin PKS (EryMod6TE) is capable of 
generating triketides in vitro on a scaled-up level from simple synthetic diketides and 
enzymatically generated building blocks. The triketide pyrone products could be readily 
observed by HPLC and characterized by NMR. Encouragingly, EryMod6TE possesses 
broad substrate specificity, which enables it to be employed as a general biocatalyst. A 
scaled-up reaction with a diketide revealed that the yields were limited to ~12% due to 
the competing side-reaction of TE-catalyzed hydrolysis of the diketide substrate. TEs 
from other synthases were fused to EryMod6; while they were capable of forming 
pyrones, they also catalyzed hydrolysis. We discovered that EryMod6TE is capable of 
‘‘stuttering’’, a phenomenon in which one module catalyzes the addition of multiple 
extender units to a growing polyketide. This ability was harnessed biocatalytically to 
generate the anticipated pyrones from monoketides. 
 
RESULTS 
Triketide pyrones from diketide substrates 
The promiscuous malonyl-CoA ligase Streptomyces coelicolor MatB was utilized 
to generate the extender unit methylmalonyl-S-NAC (3.1) (Hughes, 2011). As 
methylmalonyl groups can be transferred from 3.1 onto PKSs, costly methylmalonyl-
CoA is no longer necessary for scaled-up in vitro PKS reactions (Scheme 3-1). As the 
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described biocatalytic schemes are designed to be both rapid and inexpensive, neither 
overexpressed MatB nor EryMod6TE was purified from the lysate of the expression host.  
Each β-ketoacyl-S-NAC 3.2–3.7 was added to MatB-generated extender unit 3.1 
and lysate from Escherichia coli K207-3 cells that overexpressed EryMod6TE (Scheme 
3-1) (Murli, 2003; Piasecki, 2011). After incubating the reactions overnight at ambient 
temperature, triketide pyrones 3.8–3.13 were extracted, purified, and analyzed by reverse 
phase chromatography, LC/MS, high-resolution mass spectrometry, and 1H NMR (Table 
3-1). The C-2 methyl hydrogens and the C-4 hydrogen produced diagnostic peaks in the 
1HNMR spectra at 1.9 ppm and 5.8 ppm, respectively. Pyrones 3.8–3.13 were further 
characterized by their reverse phase chromatographic retention times and absorbance 
spectra (λmax = 288.7 nm for 3.8, 3.9, and 3.11–3.13, λmax = 292.3 nm for 3.10) (Figure 3-
1). 
HPLC analysis of triketide pyrone production under identical reaction conditions 
enabled an estimate of the relative titers obtained (assuming similar extinction 
coefficients for the pyrone products) and provided insight as to the optimal diketide 
substrate for EryMod6TE-catalyzed pyrone formation. Previous experiments 
demonstrated that EryKS6 accepts the diketide (2S, 3R)-3-hydroxy-2-methylpentanoyl-S-
NAC (Wu, 2000). Our experiments show that each of the β-ketoacyl-S-NAC substrates 
3.2–3.7 are also accepted, which indicates that the substrate specificity of EryKS6 is very 
broad. Based on the integrations of product peaks, reactions with 3.2 yielded the least 
triketide pyrone product, while reactions with 3.4 yielded the most. 
To examine the scalability of these in vitro reactions, a large-scale reaction was 
prepared using 200 mg of diketide 3.4. The reaction was complete after 24 hours, as 
monitored by reverse phase chromatography. After ethyl acetate extraction and silica gel 
purification, 20 mg of pyrone 3.11 was obtained, representing an overall yield of 12%. 
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We hypothesized that the majority of substrate 3.4 was hydrolyzed by EryTE. While we 
seek to increase the overall yield of this process, the reactants and the catalysts are easily 
and inexpensively obtained so sub-quantitative yields are tolerable. A 13C NMR of 3.11 
was readily acquired (Appendix 1). 
Triketide pyrones produced by “stuttering” 
In each of the reactions with diketide substrates and 3.1, some quantity of pyrone 
3.10 was produced. We hypothesized that this pyrone was derived from the 
decarboxylation of extender unit 3.1, priming of EryKS6 by the resulting propionyl-S-
NAC, two extension cycles (i.e. stuttering), and cyclization. Stuttering, the phenomenon 
of a module catalyzing more than one condensation, is considered normal in the 
biosynthesis of the polyketides stigmatellin (Gaitatzis, 2002), borrelidin (Olano, 2004), 
aureothin (He, 2003), and lankacidin (Mochizuki, 2003) but abnormal in the biosynthesis 
of such polyketides as epothilone (Hardt, 2001) and erythromycin (Wilkinson, 2000) (a 
small quantity of octaketide is produced by the erythromycin PKS due to stuttering by the 
fourth module). The isolated fifth module of the pikromycin PKS has been demonstrated 
to stutter in vitro, yielding a reduced triketide lactone when supplied with 
methylmalonyl-CoA and NADPH (Beck, 2003).  
With the goal of harnessing the stuttering activity of EryMod6TE to 
biocatalytically generate triketide pyrones from monoketide priming units, acyl-S-NACs 
3.14–3.18 were incubated overnight with MatB-generated 3.1 and EryMod6TE lysate 
(Scheme 3-2). Triketide pyrone products 3.19–3.22 were extracted and analyzed by 
reversed-phase chromatography, LC/MS, and high-resolution mass spectrometry (an 1H 
NMR spectrum was also obtained for 3.20) (Figure 3-2, Table 3-1, and Appendix 1). An 
estimation of pyrone production through peak integration indicates that butyryl-S-NAC 
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(3.16) is converted to pyrone through the stuttering activity of EryMod6TE to the greatest 
extent. Crotonyl-S-NAC was not detectably converted. These observations suggest that 
the greater flexibility of the butyryl group enables it to be accepted by EryKS6 more 
readily than the rigid crotonyl group. 
TE-catalyzed substrate hydrolysis 
Quantitative yields of triketide pyrones were not obtained from diketide-S-NACs 
3.2–3.7 and acyl-S-NACs 3.14–3.18 due to a side-reaction: TE-mediated thioester 
hydrolysis (Sharma, 2007). To determine how quickly different substrates hydrolyze 
under the employed reaction conditions, extender unit 3.1 was excluded from four 
EryMod6TE reactions and hydrolysis was monitored by reverse phase chromatography 
(Figure 3-3). Hydrolysis half-lives were measured to be ~5.9 h for α-substituted β-
ketoacyl-S-NAC 3.7, ~4.4 h for acyl-S-NAC 3.15, ~3.8 h for acyl-S-NAC 3.16, and ~2.0 
h for β-ketoacyl-S-NAC 3.4 (Appendix 1). 
We hypothesized that other TEs might not hydrolyze substrates as rapidly as 
EryTE, permitting a more complete conversion of a diketide substrate to a triketide 
product. The TE domains from the amphotericin PKS (Caffrey, 2003), the radicicol PKS 
(Reeves, 2008), and the calcium-dependent antibiotic NRPS (Bentley, 2002) were fused 
to EryMod6 to create EryMod6AmpTE, EryMod6RadTE, and EryMod6CdaTE (Figure 
3-4). Each of the four enzyme complexes was incubated with 3.4 and MatB-generated 
3.1. After 24 hours, each reaction had gone to completion, as judged by the disappearance 
of 3.4. Pyrone formation was analyzed by reverse phase chromatography. Each of the 
TEs catalyzed pyrone formation; however, none of the new constructs produced more 
triketide pyrone than native EryMod6TE (Figure 3-5, Appendix 1). Thus EryTE 
outperformed the other TEs, exhibiting the highest ratio of triketide pyrone cyclized to 
 48 
diketide substrate hydrolyzed. In order to obtain higher yields of triketide pyrone 
products, we are currently investigating the use of acyl-CoA ligases that will regenerate 
the thioester substrates hydrolyzed by TEs. 
 
DISCUSSION 
This study sets the stage for utilizing PKS modules biocatalytically to produce 
preparative quantities of valuable polyketides. While our goal is to produce longer 
polyketides through in vitro biocatalysis, we currently aim to generate reduced triketide 
lactone chiral building blocks useful in the syntheses of medicinally- relevant polyketides 
(Hanessian, 1993). Such molecules would be most amenable to synthetic efforts if a 
chemical handle were present at the terminus of the polyketide fragment. We 
demonstrated the feasibility of introducing such functionality through the generation of 
pyrone 3.19, which contains a terminal alkyne. The diversity of triketides pyrones formed 
using EryMod6TE as a biocatalyst reveals the substrate promiscuity of its enzymatic 
domains and illustrates the remarkable biosynthetic potential of such PKS enzymes in 
vitro. While other classes of PKSs may be useful in the biocatalytic generation of pyrones 
(e.g. chalcone synthase [Ferrer, 1999], 6-methylsalicylic acid synthase [Beck 1990]), they 
lack the versatility of modular PKSs and are incapable of synthesizing reduced 
polyketides with multiple stereocenters. Further studies of TE-catalyzed hydrolysis and 
employing acyl-CoA ligases to regenerate hydrolyzed substrate should enable higher 
yields of polyketide products. 
In addition to accelerating the total synthesis of medicinally relevant natural 
products, the described biocatalytic systems will accelerate PKS enzymology. The 
chemical structures of polyketides naturally report on the activities of the enzymes that 
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produce them. Since polyketides can now be obtained through in vitro studies in 
quantities sufficient for characterization by NMR and small-molecule crystallography, 
much more will be learned about the PKS enzymes that catalyze their formation. 
 
MATERIALS AND METHODS 
Synthesis of compounds utilized 
N-acetylcysteamine (NAC) 
Into a flask containing 20 mL deionized water was dissolved acetyl-N-
acetylcysteamine (NAC) thioester (1 mL, 9.4 mmol, 1 eq.) and sodium hydroxide (1.1 g, 
28.3 mmol, 3 eq.). The reaction was stirred for 3 hours at 23 °C and product was 
extracted with ethyl acetate (80 mL x 3). The organic layer was dried with MgSO4, and 
the product was isolated in vacuo. 
β-ketoacyl-S-NAC diketides  
The syntheses of diketides 3.2–3.4, and 3.7 were performed as previously 
described (Piasecki, 2011). Diketides 3.5 and 3.6 were synthesized using the following 
protocol: into a round-bottom flask containing anhydrous dichloromethane (50 mL) 
cooled to 0 °C was added pyridine (3.44 mL, 42 mmol, 2 eq.) and Meldrumʼs acid (3.0 g, 
20.8 mmol, 1 eq.). Hexanoyl chloride (3.49 mL, 25 mmol, 1.2 eq.) or valeryl chloride 
(2.97 mL, 25 mmol, 1.2 eq.) was added dropwise to solution and stirred overnight at 23 
°C. The reaction was washed with 0.1 M HCl (20 mL x 1) and the organic layer was 
dried, filtered, and concentrated in vacuo. The dried product (20.8 mmol, 1 eq.) and NAC 
(2.2 mL, 20.8 mmol, 1 eq.) was then refluxed in dry toluene (50 mL) for 5 hours. The 
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final product was extracted with ethyl acetate (150 mL x 3). The organic layer was dried 
with MgSO4, and the product was isolated in vacuo. 
 3-oxoheptanoyl-N-acetylcysteamine thioester (3.5) 1H NMR (400 MHz, CDCl3) δ 
5.89 (bs, 1H), 3.70 (s, 2H), 3.45 (q, J = 6.3, 2H), 3.10 (t, J = 6.5, 2H), 2.54 (t, J = 7.4, 
2H), 1.98 (s, 3H), 1.58 (m, J = 7.6, 2H), 1.32 (m, J = 7.3, 2H), 0.91 (t, J = 7.3, 3H). 
 3-oxooctanoyl-N-acetylcysteamine thioester (3.6) 1H NMR (400 MHz, CDCl3) δ 
5.89 (bs, 1H), 3.70 (s, 2H), 3.47 (q, J = 6.4, 2H), 3.10 (t, J = 6.6, 2H), 2.53 (t, J = 7.3, 
2H), 1.98 (s, 3H), 1.60 (m, J = 7.4, 2H), 1.26-1.35 (m, 4H), 0.89 (t, J = 7.2, 3H). 
4-pentynoyl-S-NAC 
Into a round-bottom flask containing anhydrous dicholoromethane cooled (50 
mL) to 0 °C was dissolved 4-pentynoic acid (50 mg, 0.51 mmol, 1.0 eq), 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (146.7 mg, 0.77 mmol, 1.5 eq.), 4-
dimethylaminopyridine (12.5 mg, 0.10 mmol, 0.2 eq.) and NAC (81.2 μL, 0.77 mmol, 1.5 
eq.). The reaction was stirred at 0 °C for 30 minutes, warmed to room temperature, and 
stirred for an additional 16 hours. The reaction was quenched using deionized water (50 
mL), and the resulting mixture was extracted with ethyl acetate (150 mL x 3). The 
organic layer was dried with MgSO4, and the product was isolated in vacuo. 
4-pentynoyl-N-acetylcysteamine thioester (3.14) 1H NMR (400 MHz, CDCl3) δ 
5.79 (bs, 1H), 3.45 (q, J = 6.5, 2H), 3.07 (t, J = 6.6, 2H), 2.82 (t, J = 7.2, 2H), 2.55 (td, J = 
2.6, 7.2, 2H), 2.00 (t, J = 2.7, 1H), 1.97 (s, 3H). 
acyl-S-NAC monoketides 
Into a round-bottom flask containing anhydrous dicholoromethane (8.5 mL) was 
added TEA (70 μL, 0.50 mmol, 1.2 eq.), NAC (45 μL, 0.42 mmol, 1 eq.), and either 37 
μL propionyl chloride, 44 μL butyryl chloride, 50 μL valeryl chloride, or 59 μL hexanoyl 
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chloride (0.42 mmol, 1 eq.). The reaction was stirred on ice for 30 minutes, warmed up to 
room temperature, and stirred for an additional hour. The reaction was quenched using 
deionized water (20 mL), and the resulting mixture was extracted with ethyl acetate (30 
mL x 3). The organic layer was dried with MgSO4, and the product was isolated in vacuo. 
 propionyl-N-acetylcysteamine thioester (3.15) 1H NMR (400 MHz, CDCl3) δ 5.86 
(bs, 1H), 3.44 (q, J = 6.3, 2H), 3.03 (t, J = 6.6, 2H), 2.61 (t, J = 7.5, 2H), 1.97 (s, 3H), 
1.19 (t, J = 7.5, 3H). 
 butyryl-N-acetylcysteamine thioester (3.16) 1H NMR (400 MHz, CDCl3) δ 5.80 
(bs, 1H), 3.44 (q, J = 6.5, 2H), 3.03 (t, J = 6.2, 2H), 2.56 (t, J = 7.6, 2H), 1.96 (s, 3H), 
1.70 (m, J = 7.4, 2H), 0.96 (t, J = 7.4, 3H). 
 valeryl-N-acetylcysteamine thioester (3.17) 1H NMR (400 MHz, CDCl3) δ 5.82 
(bs, 1H), 3.43 (q, J = 6.2, 2H), 3.02 (t, J = 6.4, 2H), 2.58 (t, J = 7.7, 2H), 1.96 (s, 3H), 
1.64 (m, J = 7.5, 2H), 1.35 (m, J = 7.5, 2H), 0.91 (t, J = 7.3, 3H). 
 hexanoyl-N-acetylcysteamine thioester (3.18) 1H NMR (400 MHz, CDCl3) δ 5.91 
(bs, 1H), 3.42 (q, J = 6.8, 2H), 3.01 (t, J = 6.3, 2H), 2.56 (t, J = 7.3, 2H), 1.95 (s, 3H), 
1.65 (m, J = 6.9, 2H), 1.30 (m, J = 3.8, 4H), 0.88 (t, J = 7.2, 3H). 
Cloning 
Restriction enzyme sites within the EryMod6TE plasmid were utilized for the 
construction of EryMod6, EryMod6AmpTE, EryMod6CdaTE, and EryMod6RadTE 
(Scheme 3-3, adapted from Menzella, 2005). 
Protein expression and purification 
MatB and EryMod6TE expression plasmids were prepared as previously 
described (Hughes, 2011). The MatB expression plasmid was transformed into 
Escherichia coli BL21(DE3) while EryMod6, EryMod6TE, EryMod6AmpTE, 
 52 
EryMod6CdaTE, and EryMod6RadTE expression plasmids were transformed into E. coli 
K207-3 cells (Murli, 2003). Starter cultures (50 mL) were grown overnight and used to 
inoculate Luria broth (2 L, 37 °C) supplemented with 50 mg/L kanamycin. The culture 
was cooled (15° C) when cells reached OD600 = 0.4, and protein expression was induced 
with 0.5 mM IPTG. After 16 hours, cells were harvested by centrifugation, resuspended 
in 50 mL lysis buffer (10% glycerol, 0.5 M NaCl, 100 mM HEPES pH 7.5), and 
sonicated. Cellular debris was removed via centrifugation (30,000 x g, 45 minutes). Both 
MatB and the five EryMod6TE lysates were dialyzed against 1 L of lysis buffer (4 °C). 
After 6 hours, the buffer was exchanged and a second round of dialysis was performed 
for an additional 16 hours of dialysis. Lysates were flash-frozen and stored at (-80) °C 
until further use. 
Methylmalonyl-S-NAC MatB reaction 
The following reaction conditions were used for the enzymatic synthesis of 
methylmalonyl-S-NAC extender unit 3.1: 300 mM HEPES pH 7.5, 120 mM adenosine 
triphosphate, 240 mM MgCl2, 100 mM methylmalonic acid, 110 mM NAC, and 10% v/v 
MatB (in dialyzed lysate). The reaction was incubated at 23 °C overnight. Synthesis of 
3.1 was verified by reverse phase HPLC (Hughes et al., 2011). The reaction was flash-
frozen and stored at (-80) °C until further use. 
Enzymatic synthesis of triketide pyrones by EryMod6TE 
Reactions were set up using the following conditions (4 mL total volume): 5% v/v 
DMSO, 300 mM HEPES pH 7.5, 10 mM 2-7, 25 mM MatB-generated 3.1, and 25% v/v 
EryMod6TE (in dialyzed lysate). After 6 hours at 23 °C, reactions were spiked with 
additional 10 mM 3.2–3.7 and incubated at 23 °C overnight. Triketide pyrone products 
were extracted using ethyl acetate (8 mL x 3) and isolated in vacuo. The pyrone product 
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was purified via flash chromatography using silica gel (with a 0.5 cm top layer of copper 
sulfate-impregnated silica gel to remove unreacted NAC) and 50% ethyl acetate in 
hexanes. Fractions were analyzed by TLC, the triketide pyrone products made visible 
through iodine staining. Product-containing fractions were combined and evaporated. 
Samples were resuspended in 50 μL pure ethanol and further purified by reverse phase 
HPLC (Waters) using a Phenomenex Bondclone 10-C18 column and a Waters 2998 
photodiode array detector set at 290 nm. The mobile phases consisted of water containing 
0.1% TFA (solvent A) and methanol containing 0.1% TFA (solvent B), and a linear 
gradient (flow rate = 2 mL/min) of 20-80% B over 10 minutes was used. Triketide pyrone 
peaks were collected, isolated in vacuo, and submitted for 1H NMR characterization (400 
MHz, CDCl3, pulse width = 90°, number of scans = 64). The molecular weights of 
compounds 3.8–3.13 were verified using LC/MS and high-resolution mass spectrometry 
(HR-MS). 
HR-MS Data 
3.8: ESI; [M + H]+ calc. m/z = 141.05462, obs. m/z = 141.05435 
3.9: ESI; [M + H]+ calc. m/z = 155.07027, obs. m/z = 155.07007 
3.10: ESI; [M + H]+ calc. m/z = 169.08592, obs. m/z = 169.08583 
3.11: ESI; [M + H]+ calc. m/z = 169.08592, obs. m/z = 169.08599 
3.12: ESI; [M + H]+ calc. m/z = 183.10157, obs. m/z = 183.10136 
3.13: ESI; [M + H]+ calc. m/z = 197.11722, obs. m/z = 197.11698 
Scaled-up synthesis of triketide pyrone 3.11 
A scaled-up synthesis of pyrone 3.11 was set up using the following conditions 
(50 mL total volume): 5% v/v DMSO, 200 mM HEPES pH 7.5, 21 mM 3.4 (200 mg, 1.0 
mmol), 25 mM MatB-generated 3.1 (25 mL, 1.25 mmol), and 25% v/v EryMod6TE (in 
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12.5 mL dialyzed lysate). After 16 hours, 100 μL of the reaction was quenched with 100 
μL pure ethanol, and then vortexed, centrifuged (10,000 x g, 1 min), and analyzed by 
HPLC as outlined in the previous section. A significant quantity of diketide 3.4 was still 
unreacted, so the reaction was spiked with an additional 2 mL of dialyzed EryMod6TE 
lysate and an additional 0.2 mmol of MatB-generated 3.1. The reaction was incubated for 
an additional 16 hours and analyzed in the same fashion as described above. Only trace 
amounts of compound 3.4 remained. Triketide pyrone 3.11 was extracted with ethyl 
acetate (150 mL x 3), dried with MgSO4, and isolated in vacuo. The pyrone was further 
purified by silica gel flash chromatography (with a 2 cm top layer of copper sulfate-
impregnated silica gel) using 50% ethyl acetate in hexanes. Fractions were analyzed by 
TLC (iodine stain). Pyrone-containing fractions were combined and evaporated. The 
residue was dried on high-vacuum for 3 hours and the quantity of pyrone product 
produced was determined to be 20 mg, which represents a yield of 11.9%. Pyrone 3.11 
was characterized both by 1H NMR (400 MHz, CDCl3, pulse width = 30°, number of 
scans = 8) as well as 13C NMR (400 MHz, CDCl3, pulse width = 30°, number of scans = 
64). 
Enzymatic synthesis of triketide pyrones via “stuttering” 
Reactions to produce triketide pyrones through the stuttering of EryMod6TE were 
set up using the following conditions (250 μL total volume): 5% v/v DMSO, 300 mM 
HEPES 7.5, 10 mM 3.14–3.18, 40 mM MatB-generated 3.1, and 25% v/v EryMod6TE 
(in dialyzed lysate). After 6 hours at 23 °C, reactions were spiked with additional 10 mM 
3.14–3.18 and incubated at 23 °C for an additional 18 hours. Triketide pyrones were 
extracted with ethyl acetate (750 μL x 3) and isolated in vacuo. Products were 
resuspended in ethanol and analyzed via reversed-phase HPLC (Waters) using a Varian 
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Microsorb-MV 100-5 C18 column and a Waters 2998 photodiode array detector set at 290 
nm. The mobile phases consisted of water containing 0.1% TFA (solvent A) and 
methanol containing 0.1% TFA (solvent B). A linear gradient (flow rate = 1 mL/min) of 
20-80% B over 10 minutes was employed. The molecular weights of 3.19–3.22 were 
characterized by LC/MS and high-resolution mass spectrometry. The 1H NMR of pyrone 
3.20 was determined (400 MHz, CDCl3, pulse width = 90°, number of scans = 64). 
HR-MS Data 
3.19: ESI; [M + H]+ calc. m/z = 193.08592, obs. m/z = 193.08561 
3.20: ESI; [M + H]+ calc. m/z = 183.10154, obs. m/z = 183.10157 
3.21: ESI; [M + H]+ calc. m/z = 197.11722, obs. m/z = 197.11716 
3.22: ESI; [M + H]+ calc. m/z = 211.13287, obs. m/z = 211.13261 
TE-catalyzed hydrolysis reactions 
The following reaction conditions were used to monitor hydrolysis by 
EryMod6TE (250 μL total volume): 5% v/v DMSO, 300 mM HEPES pH 7.5, 10 mM 
3.4, 3.7, 3.15, or 3.16, and 25% v/v EryMod6TE (in dialyzed lysate). At time points 0, 2, 
4, 6, and 8 hours, 25 μL of the reaction was quenched with 25 μL of pure ethanol, 
vortexed, and centrifuged (10,000 rcf, 5 min). Time point samples (10 μL) were analyzed 
by reversed-phase HPLC (Waters) using a Varian Microsorb-MV 100-5 C18 column and a 
Waters 2998 photodiode array detector set at 235 nm. The mobile phases consisted of 
water containing 0.1% TFA (solvent A) and methanol containing 0.1% TFA (solvent B), 
and a linear gradient (flow rate = 1 mL/min) of 20-80% B over 10 minutes was used. 
Peaks were integrated using Waters software. All peak areas for time trials were 
normalized to peak area at time = 0 hr. Each reaction was set up in triplicate, and the 
entire experiment was duplicated. 
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Activity assay of the five EryMod6TE variants 
Reactions to assay the five EryMod6TE variants for pyrone formation were set up 
with the following conditions (500 μL total volume): 300 mM HEPES pH 7.5, 10 mM of 
diketide 3.4, 20 mM MatB-generated 3.1, and 25% v/v EryMod6AmpTE (in dialyzed 
lysate), or EryMod6RadTE (in dialyzed lysate), EryMod6CdaTE (in dialyzed lysate), 
EryMod6NoTE (in dialyzed lysate), or EryMod6TE (in dialyzed lysate). Reactions were 
incubated at 23 °C overnight. After 24 hours, 100 μL from each reaction was quenched 
with 100 μL pure ethanol, vortexed, and centrifuged (10,000 x g, 1 minute). 20 μL 
samples were analyzed by reversed-phase HPLC (Waters) using a Varian Microsorb-MV 
100-5 C18 column, monitoring at both 235 nm (to detect diketide 3.4) and 290 nm (to 
detect triketide pyrone 3.11) with a Waters 2998 photodiode array detector. The mobile 
phases consisted of water containing 0.1% TFA (solvent A) and methanol containing 
0.1% TFA (solvent B). A linear gradient (flow rate = 1 mL/min) of 20-80% B over 10 
minutes was used. Triketide pyrone peak areas were integrated using Waters software. 
LC/MS analysis 
Pyrones 3.8–3.13 and 3.19–3.22 were resuspended in 25% acetonitrile and 0.1% 
formic acid and subjected to positive-ESI LC/MS (Agilent Technologies 1200 Series 
HPLC with a Gemini C18 column coupled to an Agilent Technologies 6130 quadrupole 
mass spectrometer). Mobile phases consisted of water containing 0.1% formic acid 
(solvent A) and acetonitrile containing 0.1% formic acid (solvent B). A linear gradient 
(flow rate = 0.7 mL/min) of 5-95% B over 12 minutes was employed. 
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Scheme 3-1 Semipreparative synthesis of triketide pyrones from diketides and 
methylmalonyl-S-NAC.
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Figure 3-1 Enzymatic synthesis of triketide pyrones from diketides. 
Reversed-phase chromatography traces of triketide pyrones synthesized by EryMod6TE 
from β-ketoacyl-S-NACs. 
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Table 3-1 1H NMR and LC/MS characterization of triketide pyrones. 
 
 
 
Cmpd. R1 R2 C-2 methyl Mass: (exp.) obs. 
3.8 2.21 (3H, s) 5.82 (1H, s) 1.96 (3H, s) (141.0546) 141.0544 
3.9 2.50 (2H, q, J = 7.6) 1.22 (3H, t, J = 7.6) 5.81 (1H, s) 1.96 (3H, s) 
(155.0703) 
155.0701 
3.10 2.55 (2H, q, J = 7.2) 1.21 (3H, t, J = 7.6) 1.98 (3H, s) 1.97 (3H, s) 
(169.0859) 
169.0858 
3.11 
2.43 (2H, t, J = 7.5) 
1.68 (2H, m, J = 7.5) 
0.95 (3H, t, J = 7.4)  
5.83 (1H, s) 1.96 (3H, s) (169.0859) 169.0860 
3.12 
2.45 (2H, q, J = 7.2)  
1.63 (2H, m, J = 7.2) 
1.36 (2H, m, J = 7.2) 
0.92 (3H, t, J= 7.4)  
5.84 (1H, s) 1.96 (3H, s) (183.1016) 183.1014 
3.13 
2.44 (2H, t, J = 7.6)  
1.64 (2H, m, J = 7.7) 
1.32 (4H, m, J = 7.2)  
0.90 (3H, t, J= 7.0) 
5.83 (1H, s) 1.96 (3H, s) (197.1172) 197.1170 
3.20 
2.49 (2H, t, J = 7.7) 
1.68 (2H, m, J = 7.6) 
0.95 (3H, t, J = 7.4)  
1.98 (3H, s) 1.96 (3H, s) (183.1015) 183.1016 
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Scheme 3-2 Semipreparative synthesis of triketide pyrones from monoketides and 
methylmalonyl-S-NAC via stuttering. 
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Figure 3-2 Enzymatic synthesis of triketide pyrones from monoketides. 
Reversed-phase chromatography traces of triketide pyrones synthesized by EryMod6TE 
from acyl-S-NACs via stuttering. 
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Figure 3-3 TE-mediated hydrolysis of priming units 3.4, 3.7, 3.15 and 3.16. 
Substrates were incubated with EryMod6EryTE, and TE-mediated hydrolysis was 
monitored by HPLC (peak integrations are normalized to 1 at time = 0 hours). 
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Figure 3-4 Polyketides and TE cyclization. 
Molecules cyclized by TEs of a) the erythromycin PKS, b) the radicicol PKS, c) the 
calcium-dependent antibiotic NRPS, and d) the amphotericin PKS. The esters formed 
through cyclization are highlighted in yellow.
 64 
 
Figure 3-5 Domain swapping of EryTE leads to the formation of triketide pyrones. 
Enzymatic synthesis of pyrone 3.11 by four EryMod6TEs. Quantities were normalized 
relative to the pyrone produced by EryMod6TE. 
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Scheme 3-3 Engineering EryMod6TE plasmid constructs for domain swapping 
experiments. 
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Chapter 4 Investigating the Reactivities of a Polyketide Synthase 
Module through Fluorescent Click Chemistry 
ABSTRACT 
A method using fluorescent click chemistry has been developed to rapidly, 
sensitively, and inexpensively quantify products generated by polyketide synthase 
modules. The utility of this method was demonstrated through experiments designed to 
investigate the reactivity of a module to various substrates and reaction conditions. In a 
system where the terminal module and thioesterase of the erythromycin synthase 
generates reduced diketides, ethanethiol was found to be as effective as N-
acetylcysteamine in delivering both priming units and extender units. Insights into the 
competing reactivities within the module-thioesterase were revealed through triketide 
lactone products generated from a β-ketoacyl ethanethioester substrate. The addition of 
phosphate increased enzymatic turnover, while the addition of glycerol resulted in 
thioesterase-mediated glycerolysis of priming units. 
 
INTRODUCTION 
There are many challenges associated with investigating the operation of PKS 
modules, let alone employing them for in vitro synthesize desired compounds: substrates 
such as NADPH and methylmalonyl-CoA are costly, modules are often difficult to 
express and purify, and the products generated are typically nonchromophoric. 
Traditionally, nanogram to microgram quantities of product are generated from 
radiolabeled precursors and visualized by autoradiography - thin layer chromatography 
(radio-TLC) (Menzella, 2005). While GC/MS has been employed, derivitization is 
sometimes necessary and signal-to-noise can be low (Valenzano, 2009). Recently, 
advances in biocatalytic methods have aided in scaling up module-catalyzed reactions – a 
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glucose-fueled NADPH-regeneration system can provide a constant supply of reduced 
nicotinamide coenzyme, and extender units like methylmalonyl-S-N-acetylcysteamine 
(mm-S-NAC) can be enzymatically generated by MatB for the price of ATP (Wong, 
1985; Hughes, 2011). However, the major bottleneck to investigating the reactivity of 
modules remains analyzing in vitro reactions.  
Previously, we used fluorine NMR to follow substrates containing a terminal 
trifluoromethyl group through reactions catalyzed by overexpressed PKS enzymes in the 
commonly-employed biocatalytic setting of dialyzed cell lysate (Piasecki, 2012). This 
method requires both sophisticated instrumentation and knowledge of the chemical shifts 
of generated products. We sought a more general bioorthogonal approach that would 
allow visualization of polyketide products by HPLC. Since fluorescent alkyne probes and 
click chemistry have been used to locate azide-containing glycolipids in the background 
of a zebrafish (Laughlin, 2008), we reasoned that polyketide products containing a unique 
chemical functionality could be selectively labeled by a complementary fluorophore in 
the background of bacterial cell lysate. 
 Here we showcase a quantitative detection method that reports the fate of alkynyl 
priming units in module-catalyzed reactions within cell lysate (Figure 4-1). Copper(I)-
catalyzed azide alkyne cycloaddition (CuAAC) with sulforhodamine B azide enables 
normally nonchromophoric polyketide products to be sensitively visualized and identified 
using fluorescence spectroscopy and mass spectrometry (Rostovtsev, 2002; Prasad, 
2012). Employing this method, the incorporation of ethanethiol-linked priming and 
extender units into reduced diketide compounds by the terminal module–TE of the 
erythromycin PKS (EryMod6TE) was investigated. Ethanethiol handles were found to be 
as effective as N-acetylcysteamine (NAC) handles. Competing reactivities of 
EryMod6TE were observed through the conversion of a β-ketoacyl ethanethioester 
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priming unit to triketide lactones. We also noted an increase in enzymatic turnover in a 
single-module catalyzed reaction with increased phosphate concentrations and 
thioesterase-mediated glycerolysis of priming units in reaction buffers containing 
glycerol. 
 
RESULTS 
Bioorthogonal detection of polyketide products in cell lysate 
All experiments reported here investigated the reactivity of EryMod6TE within E. 
coli cell lysate. Performing reactions in cell lysate saves the time and expense associated 
with protein purification. To obtain EryMod6TE-containing lysate, overexpressing cells 
are pelleted, resuspended, and sonicated before cell debris is removed by centrifugation. 
Subsequent dialysis places EryMod6TE in an appropriate reaction buffer and removes 
metabolites. EryMod6TE is incubated with synthetic priming and extender units before 
initiating CuAAC with sulforhodamine B azide. Resulting adducts are analyzed by 
HPLC, and LC/MS is performed as necessary to assign masses to peaks. In the 
experiments reported here, a fluorimeter was employed for optimal sensitivity, although 
UV/vis detection also provides excellent signal.  
An ethanethiol-linked extender unit 
To decrease costs associated with both investigating the reactivities of modules 
and biocatalytically producing polyketides, the use of a simplified methylmalonyl-CoA 
analog as an in vitro extender unit was investigated (Figure 4-2). Previous in vitro 
reactions have employed enzymatically- or synthetically-generated 4.1 (mm-S-NAC) 
(Hughes, 2011; Pohl, 1998); however, the one-step, multigram synthesis of 
methylmalonyl ethanethioester (mm-S-Et) 4.2 is much more economical (Figure 4-2a). 
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Thus, EryMod6TE was incubated with priming unit 4.3, extender unit 4.1 or 4.2, and the 
NADPH regeneration system to produce reduced diketide 4.5 (Figure 4-2b; Appendix 2). 
After 16 hrs, reactions were subjected to CuAAC with sulforhodamine B azide and 
analyzed by HPLC (Figures 4-2c–d; Appendix 2). 
The analysis revealed approximately equal quantities of 4.5* (asterisks denote 
sulforhodamine adducts) were generated in reactions employing 4.1 or 4.2; ~35% of the 
priming unit 4.3 was accepted, extended, reduced, and hydrolyzed by EryMod6TE to 
afford reduced diketide 4.5. Analysis also showed that ~50% of priming unit 4.3 was 
hydrolyzed to carboxylic acid 4.4 (Figures 4-2c-d). TE-catalyzed hydrolysis of priming 
units has been previously implicated in the low yields (~10%) of EryMod6TE-catalyzed 
reactions (Hughes, 2012; Harper, 2012). Remaining 4.3 from the overnight incubations 
may not have reacted due to the gradual loss of EryMod6TE activity - precipitate was 
noticeable in reactions after 6 hrs.  
To demonstrate the use of extender unit 4.2 in the preparative, biocatalytic 
syntheses of polyketides, 17 mg of 4.3 and 13 mg of 4.2 were incubated with 
EryMod6TE lysate and the NADPH regeneration system. After 16 hrs, the reaction was 
acidified, extracted with ethyl acetate, and chromatographed to afford 3 mg of reduced 
diketide 4.5 (22% yield; Appendix 2). The difference between analytical and preparative 
reaction yields is likely due to losses during purification. 
Ethanethiol-linked priming units 
Since the NAC handle of extender unit 4.1 could be replaced by ethanethiol, we 
investigated replacing the NAC handle of priming unit 4.3 with ethanethiol. Thus, 
EryMod6TE was incubated with the NADPH regeneration system, extender unit 4.2, and 
either NAC-linked 4.3 or ethanethiol-linked 4.9 (Figures 4-3a-b). After 16 hrs reactions 
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were subjected to CuAAC with sulforhodamine B azide and analyzed by HPLC (Figure 
4-3c; Appendix 2). A comparison of the amount of 4.5* formed from priming units 4.3 
and 4.9 revealed that EryMod6TE did not significantly discriminate between NAC or 
ethanethiol priming unit handles. Building on these results, the promiscuity of 
EryMod6TE towards NAC- and ethanethiol-linked priming units of varying chain length 
was assayed. The analysis showed less than 5% difference in product formation between 
reduced diketide products 4.13* and 4.14* (Figure 4-3d). Thus EryMod6TE does not 
significantly discriminate between priming units based on chain length or handle. 
Reactivity of EryMod6TE towards a β-ketoacyl ethanethioester 
Having analyzed reactions employing priming units 4.3 and 4.6-4.10 in the 
module-catalyzed generation of reduced diketides, we were interested in probing the 
reactivity EryMod6TE with a more advanced priming unit, such as β-ketoacyl 
ethanethioester 4.15. The chemical synthesis of 4.15 was performed by C-acylation of 5-
hexynoic acid with 4.2 through a reaction developed by Masamune and coworkers 
(Brooks, 1979). Briefly, 4.2 was reacted with magnesium ethoxide to form its magnesium 
salt, 5-hexynoic acid was reacted with carbonyldiimidizole to form its imidazolide, and 
these intermediates were reacted with one another. EryMod6TE was incubated for 16 hrs 
with priming unit 4.15, extender unit 4.2, and the NADPH regeneration system. The 
reaction was subjected to CuAAC with sulforhodamine B azide and analyzed by HPLC 
(Figures 4-4a–c; Appendix 2). 
Interestingly, 4.15 was reduced by EryKR6 yielding at least two reduced 
stereoisomers (Figures 4-4a–c). EryKS6 accepted at least one stereoisomer of 4.17 since 
extension followed by cyclization yielded ketolactone 4.19 while extension followed by 
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another round of EryKR6-mediated reduction prior to cyclization yielded hydroxylactone 
4.20. 
Phosphate increases substrate turnover 
Increased turnover numbers for triketide lactone formation by the bimodular 
DEBS1+TE (the first polypeptide of the erythromycin PKS fused to EryTE) were 
observed with increases in phosphate concentration (Pieper, 1996). To determine whether 
phosphate has a similar effect on single-module constructs, EryMod6TE was incubated 
with 0–100 mM phosphate, priming unit 4.3, extender unit 4.2, and the NADPH 
regeneration system (Figure 4-5a). After 2 and 16 hrs, reactions were subjected to 
CuAAC with sulforhodamine B azide and analyzed by HPLC (Figures 4-5b–c).  
After 2 hours, 20% of 4.3 was converted to 4.5 in the absence of phosphate, while 
31% had been converted in the presence of 100 mM phosphate (Figure 4-5b). After 2 hrs, 
43% of 4.3 remained unreacted in the absence of phosphate, whereas only 20% remained 
unreacted in the presence of 100 mM phosphate. After 16 hrs, no 4.3 remained and no 
precipitate was observed in reactions containing at least 50 mM phosphate (Figure 4-5c).  
TE-catalyzed glycerolysis 
Previously, glycerol has been used to prevent precipitation of EryMod6TE in 
dialyzed lysate (Hughes, 2012; Harper, 2012); however, HPLC analysis of EryMod6TE-
catalyzed reactions in the presence of glycerol yielded a large, unanticipated peak (4.21*, 
Figure 4-6b). LC/MS and 1H NMR analysis confirmed that this peak resulted from 
priming unit glycerolysis (Figure 4-6a; Appendix 2). A panel of single and double 
knockout mutants of EryMod6TE was assayed for the ability to generate 4.21 (∆KS, 
∆AT, ∆TE, ∆KS+AT, ∆KS+TE, and ∆AT+TE; catalytic nucleophiles replaced by 
alanines). Through these experiments, TE activity was linked to the generation of 4.21 
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(Figure 4-6c; Appendix 2). TE-catalyzed glycerolysis was confirmed when 4.21* was 
observed from the incubation of purified EryTE with 4.3 in a glycerol-containing buffer 
(Appendix 2). 
 
DISCUSSION 
A method for monitoring in vitro polyketide synthesis has been developed with 
several advantages over traditional techniques such as radio-TLC and GC/MS. Polyketide 
products, which are typically nonchromophoric, are made brightly fluorescent in a 
simple, rapid, inexpensive, and bioorthogonal manner upon CuAAC with sulforhodamine 
B azide. The terminal alkyne moiety is easily incorporated into synthetic priming units, 
and based on the studies reported here, is well-tolerated by PKS enzymes.  
We employed this method to compare the reaction profiles of EryMod6TE either 
incubated with ethanethiol-linked priming and extender units or with the equivalent 
NAC-linked substrates. Since no significant difference exists between these handles in 
their ability to deliver substrates in vitro, those investigating the reactivities of modules or 
using them biocatalytically may benefit from employing the ethanethiol handle. 
Several insights into the reactivity of EryMod6TE were made from its incubation 
with the β-ketoacyl ethanethioester priming unit 4.15. Even though this substrate 
possesses an ethanethiol handle, it was reduced to both syn- and anti- products by 
EryKR6 (this KR also exhibits little stereocontrol towards α-methyl, β-ketopentanoyl-S-
NAC) (Siskos, 2005). However, at least one of the reduced α-methyl, β-hydroxyacyl 
stereoisomers is extended, as evidenced by the significant production of ketolactone 4.19 
and hydroxylactone 4.20. The relative quantities of 4.19 and 4.20 may indicate that 
EryKR6 kinetically outcompeted EryTE for the ACP-bound intermediate, as observed in 
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preparative reactions with substrates not containing a terminal alkyne (Harper, 2012). 
Based on previous studies in which β-ketoacyl-S-NAC substrates were converted into 
pyrones by EryMod6TE (Hughes, 2012), some pyrone formation was anticipated from 
4.15; however, pyrone was not generated at a detectable level. This suggests that the α-
methyl, β-ketoacyl group is infrequently extended by EryKS6. 
Reaction conditions were investigated using the described method. As reported 
for DEBS1+TE, phosphate had a beneficial effect on the activity of EryMod6TE. In the 
presence of 50 mM phosphate, the priming unit substrate was completely turned over by 
EryMod6TE, apparently owing to enhanced enzyme stability. Reaction conditions that 
include glycerol should be used with caution since glycerol was found to attack acyl-TE 
intermediates, effecting the glycerolysis of the priming unit substrate. To our knowledge, 
this is the first time TE-mediated glycerolysis activity has been reported. 
TE-catalyzed hydrolysis was responsible for the largest loss of the priming unit 
substrate (>50%). Before the PKS module-catalyzed synthesis of new compounds 
becomes routine, reaction yields must be increased. Ideally, priming units would not be 
substrates for TE hydrolysis. In recent biocatalytic studies employing modular constructs 
from the pikromycin PKS, greater than 60% yields were obtained in experiments 
employing thiophenol-linked priming units (Hansen, 2013). We are now investigating a 
panel of alkyne-containing priming units that display decreased TE-mediated hydrolysis 
while remaining substrates for KSs.  
The described method will help to answer many fundamental questions of single- 
and bimodular systems in vitro. Through its bioorthogonal nature, it may also be useful in 
the quantitation of polyketide intermediates and products in vivo. The precursor-directed 
biosynthesis of 15-propargyl erythromycin A was accomplished using a priming unit 
containing a terminal alkyne (Harvey, 2012), and directed evolution by Schulz and 
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coworkers led to the incorporation of a terminal alkyne-containing extender unit by 
EryAT6 (Sundermann, 2012). Applying the described method to such systems would be 
very informative, especially for engineered versions of the erythromycin synthase that do 
not produce products expected of them. In general, we anticipate the described method to 
greatly accelerate the investigation and optimization of PKS-catalyzed biosynthesis of 
complex polyketide products. 
 
MATERIALS AND METHODS 
Synthesis of compounds utilized 
Methylmalonyl-N-acetylcysteamine thioester 
Mono-tert-butyl methylmalonic acid. To methyl meldrum’s acid (8.5 g, 138 
mmol) was added tert-butanol (40 mL) and pyridine (2 mL). The mixture was heated at 
80 °C for 24 hrs. The reaction was then cooled to 23 °C and concentrated in vacuo to 
furnish mono-tert-butyl methylmalonic acid.  
Tert-butyl-methylmalonyl-N-acetylcysteamine. To a stirred solution of 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI; 3.9 g, 21 mmol, 1.1 
eq) in dichloromethane (DCM, 60 mL) at 23 °C was added triethylamine (TEA; 2.9 mL, 
21 mmol, 1.1 eq). To the yellow solution was added the mono-tert-butyl methylmalonic 
acid (3.0 g, 19 mmol, 1.0 eq) followed by N-acetylcysteamine (NAC; 2.0 mL, 21 mmol, 
1.1 eq). The resulting solution was stirred for 48 hrs, then diluted with ethyl acetate (50 
mL) and washed with 0.1 M HCl (4 x 10mL). The organic layer was dried over sodium 
sulfate and concentrated in vacuo. 
Methylmalonyl-S-N-acetylcysteamine. To a stirred solution of tert-butyl-
methylmalonyl-S-NAC (500 mg, 1.8 mmol, 1.0 eq) in DCM (9 mL) at 0 °C under argon 
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was added 4.0 M HCl in dioxane (4.5 mL, 18 mmol, 10.0 eq). After 18 hrs, the reaction 
was concentrated in vacuo and purified by dry flash column chromatography (silica, 
eluting with 10:1 DCM:methanol) to afford compound 1. 1H NMR characterization was 
consistent with a previously reported synthesis (Pohl 1998). 
methylmalonyl-N-acetylcysteamine thioester (mm-S-NAC, 4.1) 1H NMR (400 
MHz, CDCl3) δ 3.71 (q, 1H, J = 7.2), 3.48 (q, 2H, J = 6.0), 3.10 (dtd, 2H, J = 47.6, 14.2, 
6.4), 1.98 (s, 3H), 1.45 (d, 3H, J = 7.2) 
Methylmalonyl-ethanethiol thioester 
To a round-bottom flask charged with methylmalonic acid (10 g, 5 mmol, 1.0 eq), 
was added 4-dimethylaminopyridine (DMAP; 1 g, 8.5 mmol, 0.1 eq) followed by toluene 
(250 mL). Upon stirring, phosphoryl chloride (POCl3; 8.8 mL, 93 mmol, 1.1 eq) was 
added followed by the dropwise addition of ethanethiol (6.9 mL, 93 mmol, 1.1 eq). The 
reaction was heated to 60 °C under an argon atmosphere. After 18 hrs, the reaction was 
cooled to 23 °C and concentrated in vacuo. The residue was suspended in DCM, and 
purified via dry flash column chromatography (silica, eluting with an ethyl 
acetate:hexanes gradient from 1:9 to 1:3) to furnish compound 2. 
Methylmalonyl ethanethiol thioester (4.2) 1H NMR (400 MHz, CDCl3) δ 3.67 (q, 
1H, J = 7.1), 2.94 (q, 2H, J = 7.4), 1.47 (d, 3H, J = 7.2), 1.28 (t, 3H, J = 7.4) 
NAC- and ethanethiol-linked monoketides  
To a round-bottom flask charged with 75 mL of anhydrous DCM cooled to 0 °C 
under an atmosphere of argon was dissolved EDCI (1.054 g, 5.5 mmol, 1.1 eq), TEA 
(773 µL, 5.5 mmol, 1.1 eq), 4-pentynoic acid (6 and 8, 490 µL, 5.0 mmol, 1.0 eq) or 5-
hexynoic acid (3 and 9, 562 µL, 5.0 mmol, 1.0 eq) or 6-heptynoic acid (7 and 10, 633 µL, 
5.0 mmol, 1.0 eq), and catalytic DMAP (307 mg, 2.5 mmol, 0.5 eq). The reaction was 
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stirred on ice for 10 min before the addition of NAC (3, 6–7, 504 µL, 4.75 mmol, 0.95 
eq) or ethanethiol (8–10, 342.3 µL, 4.75 mmol, 0.95 eq) and was allowed to warm to 
room temperature. After 16 hrs, the reaction was concentrated in vacuo and the remaining 
oil was resuspended in 50 mL of water. The product was extracted with ethyl acetate (1 x 
150 mL) and the organic layer was washed with 0.1 M HCl (2 x 50 mL) and saturated 
sodium bicarbonate (1 x 50 mL). The organic layer was dried over anhydrous sodium 
sulfate, and product was concentrated in vacuo. Products were purified by dry flash 
column chromatography (silica, eluting with 10:90 ethyl acetate:hexanes) to afford title 
compounds 3, 6–10. Products were characterized by 1H NMR. 
5-hexynoyl-S-N-acetylcysteamine (4.3) 1H NMR (400 MHz, CDCl3) δ 5.80 (bs, 
1H), 3.44 (q, 2H, J = 6.0), 3.04 (t, 2H, J = 6.6), 2.74 (t, 2H, J = 7.6), 2.26 (dt, 2H, J = 
6.9, 2.6), 1.99 (t, 1H, J = 2.6), 1.97 (s, 3H), 1.89 (m, 2H, J = 7.7) 
4-pentynolyl-S-N-acetylcysteamine (4.6) 1H NMR (400 MHz, CDCl3) δ 5.78 (bs, 
1H), 3.44 (q, 2H, J = 6.0), 3.06 (t, 2H, J = 6.6), 2.81 (t, 2H, J = 7.3), 2.54 (dt, 2H, J = 7.2 
and 2.6), 1.99 (t, 1H, J = 2.6), 1.96 (s, 3H) 
6-heptynoly-S-N-acetylcysteamine (4.7) 1H NMR (400 MHz, CDCl3) δ 5.80 (bs, 
1H), 3.43 (q, 2H, J = 6.1), 3.03 (t, 2H, J = 6.6), 2.61 (t, 2H, J = 7.3), 2.21 (dt, 2H, J = 7.1, 
2.7), 1.97 (s, 3H), 1.96 (t, 1H, J = 2.7), 1.79 (m, 2H, J = 7.6), 1.60-1.53 (m, 2H, J = 7.1) 
4-pentynoyl-S-N-ethanethiol thioester (4.8) 1H NMR (400 MHz, CDCl3) δ 2.90 
(q, 2H, J = 7.4), 2.77 (t, 2H, J = 7.2), 2.53 (dt, 2H, J = 6.8 and 2.6), 1.98 (t, 1H, J = 2.6), 
1.25 (t, 3H, J = 7.4) 
5-hexynoyl-S-ethanethiol (4.9) 1H NMR (400 MHz, CDCl3) δ 2.88 (q, 2H, J = 
7.4), 2.68 (t, 2H, J = 7.2), 2.25 (dt, 2H, J = 6.9 and 2.8), 1.98 (t, 1H, J = 2.7), 1.88 (m, 
2H, J = 7.8), 1.25 (t, 3H, J = 7.4) 
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6-heptynoyl-S-ethanethiol (4.10) 1H NMR (400 MHz, CDCl3) δ 2.87 (q, 2H, J = 
7.4), 2.57 (t, 2H, J = 7.3), 2.21 (dt, 2H, J = 7.0, 2.6), 1.95 (t, 1H, J = 2.6), 1.79 (m, 2H, J 
= 7.8), 1.60-1.53 (m, 2H, J = 7.5), 1.25 (t, 3H, J = 7.4) 
β-ketoacyl-S-ethanethiol diketide 
To a round-bottom flask charged with a stir bar and 4.2 (50 µL, 0.37 mmol, 2.0 
eq) under an atmosphere of argon was added anhydrous tetrahydrofuran (THF; 1 mL) and 
magnesium ethoxide (21.4 mg, 0.19 mmol, 1.0 eq). To a separate round-bottom flask 
charged with a stir bar and 5-hexynoic acid (63 µL, 0.56 mmol, 3.0 eq) under an 
atmosphere of argon was added anhydrous THF (3 mL) and carbonyldiimidazole (CDI; 
90.8 mg, 0.56 mmol, 3.0 eq). Reactions were stirred at room temperature. After 1 hr, the 
reaction generating the magnesium salt of methylmalonyl ethanethioester was 
concentrated in vacuo. To the residue, the solution of the acyl imidazole was added, and 
the reaction was stirred under argon for an additional 16 hrs. The reaction was 
concentrated in vacuo and resuspended in 0.1 M HCl (10 mL) and ethyl acetate (50 mL). 
The organic layer was washed with 0.1 M HCl (1 x 30 mL) and then with saturated 
sodium chloride (1 x 10 mL). The organic layer was dried over anhydrous sodium sulfate, 
and product was isolated in vacuo. The product was purified by dry flash column 
chromatography (silica, eluting with 5:95 ethyl acetate:hexanes) to afford compound 15.  
(2RS)-methyl-3-oxo-hept-6-ynoyl-S-ethanethiol (4.15) 1H NMR (400 MHz, 
CDCl3) δ 3.74 (q, 2H, J = 7.1), 2.92 (q, 2H, J = 7.4), 2.79 (m, 2H, J = 27.6), 2.22 (m, 
2H), 1.94 (t, 1H, J = 2.6), 1.38 (d, 3H, J = 7.1), 1.26 (t, 3H, J = 7.4) 
Sulforhodamine B azide  
Synthesis of 2-azidoethanol followed previously described method (Lu, 2005). A 
25 mL Schlenk flask was charged with 2-azidoethanol (17 mg, 0.19 mmol, 1.1 eq), TEA 
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(2.6 μL, 0.19 mmol, 1.1 eq) and DCM (5 mL). The resulting solution was cooled to 0 °C 
and allowed to stir for 10 min. A sulforhodamine B acid chloride solution in 5 mL DCM 
(100 mg, 0.17 mmol, 1.0 eq) was subsequently added dropwise via syringe. The resulting 
solution was stirred at 0 °C for 30 min and then allowed to stir at room temperature. 
Upon reacting for 12 hrs, the product was isolated in vacuo to afford a metallic green 
residue. The product was first to elute upon purification by dry flash column 
chromatography (silica, eluting with 90:10 chloroform:methanol).  
Engineering EryMod6TE mutant plasmids 
Formation of mutant plasmids were engineering using an efficient one-step, site-
directed mutagenesis protocol (Liu, 2008) of EryMod6TE plasmid with the following 6 
primers (bold depicts overlapping region and alanine residue is underlined): (1) ΔKS 
C→A forward 5’-ACCTGTGCCGTCGGAGAAGGTCGGACCACCGGAATGTGA- 
GGCGAACACCG-3’, (2) ΔKS C→A reverse 5’-GGCTTAGAAGGTCCGGCGGTAA- 
CCGGGACACGGCAGCCTCTTCCAGCC-3’, (3) ΔAT S→A forward 5’-
CGGCAA- TAGCCAGTACGAGTCCCGCTTTAACGCCGCCGGCAGCAC-3’ (4) 
ΔAT S→A reverse 5’-CGTGTGGGGTGAGCCCGTCAGCCGTTATCGGTCAT-
GCTCAGGGC-3’, (5) ΔTE S→A forward 5’-CAGGCCACGCCGCCGGCGCACT-
CATGGCCTATGCACTCGCGAC-3’, and (6) ΔTE S→A reverse 5’- CGTGGGAACC-
ACTGTTTGGAAAGCACCATCGTCCGGTGCGGCGGCCGC-3’. 
ΔKS, ΔAT, ΔTE Plasmids 
PCR reaction conditions to engineer ΔKS, ΔAT and ΔTE plasmids was performed 
using the following conditions (50 mL total volume reactions): 1X Phusion GC buffer, 5 
ng EryMod6TE plasmid, 1 mM each corresponding forward and reverse primers, 200 
mM dNTPs, 3% v/v DMSO and 3 U Phusion DNA polymerase. 
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ΔKS+AT Plasmid 
PCR reaction conditions to engineer ΔKS+AT plasmid was performed using the 
following conditions (50 mL total volume reactions): 1X Phusion GC buffer, 5 ng ΔAT 
plasmid, 1 mM each ΔKS forward and reverse primers, 200 mM dNTPs, 3% v/v DMSO 
and 3 U Phusion DNA polymerase. 
ΔKS+TE Plasmid 
PCR reaction conditions to engineer ΔKS+TE plasmid was performed using the 
following conditions (50 mL total volume reactions): 1X Phusion GC buffer, 5 ng ΔTE 
plasmid, 1uM each ΔKS forward and reverse primers, 200 mM dNTPs, 3% v/v 
DMSOand 3 U Phusion DNA polymerase. 
ΔAT+TE Plasmid 
PCR reaction conditions to engineer ΔAT+TE plasmid was performed using the 
following conditions (50 mL total volume reactions): 1X Phusion GC buffer, 5 ng ΔTE 
plasmid, 1 mM each ΔAT forward and reverse primers, 200 mM dNTPs, 3% v/v DMSO 
and 3 U Phusion DNA polymerase. 
Protein expression, dialysis, and purification 
The formation of EryMod6TE plasmid was described previously, and site-
directed mutagenesis of EryMod6TE plasmid was performed to engineer mutant plasmids 
(Appendix 2) (Liu, 2008). EryMod6TE expression plasmids were transformed into E. coli 
K207-3 cells (Murli, 2003), while the glucose dehydrogenase (GDH) and the EryTE 
expression plasmids were each transformed into E. coli BL21(DE3) cells (Piasecki, 
2012). Starter cultures (60 mL) were grown overnight and used to inoculate Luria broth 
supplemented with 50 mg/L kanamycin (6 L, 37 °C). Cultures were cooled to 15 °C after 
cells reached OD600 = 0.4, and protein expression was induced (0.5 mM IPTG). After 16 
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hrs, cells were harvested by centrifugation (4,500 x g, 10 min) and resuspended in 40 mL 
lysis buffer (0.5 M NaCl, 30 mM HEPES pH 7.5). Cells were lysed via sonication, and 
cellular debris was removed (centrifugation at 30,000 x g, 60 min). EryMod6TE and 
GDH lysates were dialyzed against 1 L lysis buffer at 4 °C. After 4 hrs, the buffer was 
exchanged with 1 L fresh lysis buffer, and allowed to dialyze for an additional 16 hrs. 
Lysates were centrifuged (4,000 x g, 10 min), flash-frozen, and stored at -80 °C until 
further use. EryTE was further purified for TE-mediated hydrolysis experiments by 
passing the cell lysate over a nickel-NTA column equilibrated with lysis buffer. The 
column was washed with lysis buffer containing 15 mM imidazole (25 mL) and protein 
was eluted with lysis buffer containing 150 mM imidazole (5 mL). 
EryMod6TE reaction conditions 
The following stock solutions were prepared: 1.5 M Tris-HCl pH 7.5, 5 M NaCl, 
3 M glucose, 100 mM NADP+, 0.5 M 4.1 and 4.2 in DMSO, and 0.1 M 4.3, 4.6-4.10 in 
DMSO. Tris-HCl pH 7.5 (150 mM), NaCl (100 mM), glucose (500 mM), NADP+ (10 
mM), extender unit 4.1 or 4.2 (5 mM), priming unit 4.3 or 4.6-4.10 (2.5 mM), pure 
DMSO (5% v/v), water, dialyzed GDH lysate (10% v/v), and dialyzed EryMod6TE 
lysate (25% v/v) were combined (200 mL reaction volume) in a microcentrifuge tube. 
After addition of each dialyzed enzyme lysate, reactions were gently mixed by pipetting 
and then centrifuged (3000 x g, 5 sec). Reactions were incubated at 23 °C for 16 hrs 
before being subjected to CuAAC with sulforhodamine B azide. Negative control 
reactions contained all substrates except for EryMod6TE dialyzed lysate. Reactions were 
performed in duplicate. 
 81 
Preparative in vitro synthesis of reduced diketide 4.5 
Tris-HCl pH 7.5 (150 mM), NaCl (100 mM), glucose (500 mM), NADP+ (10 
mM), extender unit 4.2 (5 mM), priming unit 4.3 (2.5 mM), pure DMSO (total 5% v/v), 
water, dialyzed GDH lysate (10% v/v), and dialyzed EryMod6TE lysate (25% v/v) were 
combined in a conical tube in a total volume of 25 mL. After the addition of each 
dialyzed lysate, reactions were gently mixed by pipetting and then centrifuged (3000 x g, 
5 sec). After 16 hrs, the reaction was washed using diethyl ether (1 x 50 mL). The 
aqueous layer was then acidified using 12 N HCl (2 mL) and products were extracted 
with ethyl acetate (3 x 150 mL). The organic layer was dried over sodium sulfate and 
concentrated in vacuo. Diketide 4.5 was purified by dry flash column chromatography 
(silica, eluting with 10:89:1 ethyl acetate:hexanes:acetic acid). 
Phosphate-containing reaction conditions 
Tris-HCl pH 7.5 (150 mM), NaCl (100 mM), extender unit 4.2 (5 mM), priming 
unit 4.3 (2.5 mM), pure DMSO (total 5% v/v), Na2HPO4 pH 7 (0, 10, 50 or 100 mM), 
water, dialyzed GDH lysate (10% v/v) and dialyzed EryMod6TE lysate (25% v/v) were 
combined (200 mL total volume) in a microcentrifuge tube. After addition of each 
dialyzed lysate, reactions were gently mixed by pipetting and then centrifuged (3000 x g, 
5 sec). Reactions were incubated at 23 °C for 16 hrs before being subjected to CuAAC 
with sulforhodamine B azide. Negative control reactions contained all substrates except 
for EryMod6TE dialyzed lysate. Reactions were performed in duplicate. 
Glycerol-containing reaction condition 
Reactions were prepared as described in “Conditions for EryMod6TE reactions” 
except for the use of 10% v/v glycerol and EryMod6TE knockouts (25% v/v; ∆KS, ∆AT, 
∆TE, ∆KS+AT, ∆KS+TE, and ∆AT+TE). In the experiment with purified EryTE, Tris-
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HCl pH 7.5 (150 mM), NaCl (100 mM), priming unit 4.3 (2.5 mM), glycerol (10% v/v), 
water, and nickel-purified EryTE (25% v/v) were added (200 mL total volumne) to a 
microcentrifuge tube. Reactions were incubated at 23 °C for 16 hrs before being 
subjected to CuAAC with sulforhodamine B azide. 
CuAAC reaction conditions 
The following stock solutions were prepared: 10 mM sulforhodamine B azide in 
DMSO, 1 M sodium ascorbate, and 0.5 M copper(II) sulfate. DMSO (50% v/v), 
sulforhodamine B azide (1 mM), EryMod6TE reaction (0.75 mM), and sodium ascorbate 
(40 mM) were combined (48 mL total volume) in a microcentrifuge tube. Reactions were 
vortexed and centrifuged (3000 x g, 5 sec). Copper(II) sulfate (20 mM) was then added 
and immediately vortexed for 3 seconds to initiate the click reaction. Samples were 
incubated at 23°C for 1 hr and stored at -80 °C until further use.  
HPLC and fluorescence detection 
Reactions subjected to CuAAC were centrifuged to remove debris (20,000 x g, 2 
min). Samples (20 mL) were analyzed using a Waters Symmetry C18 3.5 µm 4.6 x 75 
mm column on a Beckman Coulter System Gold 126 Solvent Module equipped with a 
Jasco FP-2020 Plus Intelligent Fluorescence Detector (λex = 565 nm, λem = 586 nm). The 
mobile phases consisted of degassed, deionized water + 0.1% TFA (solvent A) and 
degassed acetonitrile + 0.1% TFA (solvent B). A linear gradient (flow rate = 1 mL/min) 
of 75% to 55% B over 40 min followed by 10 min at 100% B was used to analyze 
reactions. Data was analyzed using 32 Karat Software. 
LC/MS analysis 
Whole reactions or compounds collected from HPLC runs were subjected to 
negative-ESI LC/MS (Agilent Technologies 1200 Series HPLC with a Gemini C18 
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column coupled to an Agilent Technologies 6130 quadrupole mass spectrometer). Mobile 
phases consisted of water containing 0.1% formic acid (solvent A) and acetonitrile 
containing 0.1% formic acid (solvent B). A linear gradient (flow rate = 0.7 mL/min) of 
5%–95% B over 12 min was used. 
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Figure 4-1 Lighting up polyketide products through fluorescent click chemistry. 
a) The sulforhodamine B azide fluorophore. b) Terminal alkyne priming units and 
methylmalonyl extender units are incubated with PKS constructs. Polyketide products are 
analyzed by copper(I)-catalyzed azide alkyne cycloaddition (CuAAC, click chemistry) 
with the fluorophore and adducts were monitored by reverse-phase HPLC. (KS, 
ketosynthase; AT, acyltransferase; KR, ketoreductase; ACP, acyl carrier protein; TE, 
thioesterase). 
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Figure 4-2 A comparison of in vitro extender units. 
a) Methylmalonyl-S-N-acetylcysteamine (mm-S-NAC, 4.1) and methylmalonyl-S-
ethanethiol (mm-S-Et, 4.2). b) Reduced diketide 4.5 is produced by EryMod6TE from 
priming unit 4.3, extender unit 4.1 or 4.2, and the NADPH regeneration system. EryTE-
mediated hydrolysis of 4.3 yields 4.4. c) Fluorimeter-coupled HPLC analysis of reactions 
(λex = 565 nm, λem = 586 nm). Adduct masses were determined by LC/MS. d) 
EryMod6TE uses extender units 4.1 and 4.2 interchangeably, as determined through a 
comparison of the peak areas of 4.3*–4.5* (asterisks indicate sulforhodamine adducts). 
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Figure 4-3 EryKS6 promiscuity towards thiol handles and chain lengths. 
a) Terminal alkyne thioester priming unit substrates. b) Reduced diketides 4.5, 4.13, and 
4.14 are generated by EryMod6TE from priming units shown in the previous panel, 
extender unit 4.2, and the NADPH regeneration system. EryTE-catalyzed hydrolysis of 
the priming units yields carboxylic acids 4.4, 4.11, and 4.12. c) Equivalent product 
profiles are observed for NAC-linked priming unit 4.3 and ethanethiol-linked priming 
unit 4.9. d) Equivalent product profiles are observed for substrates of varying chain 
length, regardless of thiol handle. 
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Figure 4-4 EryMod6TE reactivity towards an advanced priming unit. 
a) β-Ketoacyl ethanethioester 4.15 is reduced by EryKR6. At least one of the resulting 
stereoisomers (4.17) is extended by EryKS6. EryTE-mediated cyclization yields 
ketolactone 4.19, while EryKR6-mediated reduction followed by EryTE-mediated 
cyclization yields hydroxylactone 4.20. EryTE also hydrolyzes diketides 4.15 and 4.17 to 
yield 4.16 and 4.18a-b, respectively. b) Reverse-phase HPLC analysis of reactions (λex = 
565 nm, λem = 586 nm). Diastereomer(s) 4.18a are syn and diastereomer(s) 4.18b are anti, 
as the retention time of 4.18a* matches that of 4.5*. c) A bar graph compares the peak 
areas from the previous panel. 
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Figure 4-5 Phosphate enhances turnover. 
a) EryMod6TE operating as a reduced diketide synthase. b) A comparison of peak areas 
for 2 hr reactions shows increased substrate turnover with phosphate concentration. c) A 
comparison of peak areas for 16 hr reactions shows complete substrate turnover when the 
phosphate concentration is at least 50 mM. 
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Figure 4-6 EryTE-mediated glycerolysis of priming units. 
a) TE-mediated hydrolysis has been implicated in low biocatalytic product yields. Here 
EryTE is also shown to catalyze glycerolysis in reaction buffers containing glycerol. b) 
An HPLC trace (λex = 565 nm, λem = 586 nm) reveals the generation of both the hydrolysis 
product 4.4 and the glycerolysis product 4.21 from priming unit 4.3. c) EryMod6TE 
mutants containing an active EryTE produce significant quantities of glycerolysis product 
4.21.  
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Chapter Five: Conclusions  
 
Here, we demonstrated the S. coelicolor MatB-catalyzed synthesis of polyketide 
extender units malonyl-CoA, methylmalonyl-CoA, ethylmalonyl-CoA, methoxymalonyl-
CoA, and hydroxymalonyl-CoA, marking the first enzymatic syntheses of 
methoxymalonyl-CoA and hydroxymalonyl-CoA. Equivalent PANT- and NAC-linked 
extender units were also generated, demonstrating that MatB was not only promiscuous 
toward malonyl derivatives, but also thiol acceptors. Crystal structures of two MatB 
ternary product complexes were obtained with malonyl-CoA and AMP and (2R)-
methylmalonyl-CoA and AMP bound (1.45 Å and 1.43 Å resolution, respectively). These 
are the first structures of a diacid-activating adenylate-forming enzyme. The strong 
electron density surrounding the protein, thioester product, and AMP provides some of 
the most complete snapshots of product formation in the enzyme superfamily. The 
orientation of the (2R)-methylmalonyl-CoA α-methyl group reveals the stereoselectivity 
of MatB as well as the pocket that enables MatB to be promiscuous toward the α-
substituents of the diacid. MatB generated CoA-, PANT- and NAC-linked 
methylmalonyl extender units were employed in the synthesis of a triketide pyrone, 
exemplifying the use of MatB for in vitro PKS reactions.  
We showed EryMod6TE was capable of generating triketides in vitro on a scaled-
up level from simple synthetic diketides and enzymatically generated building blocks. 
The triketide pyrone products were readily observed by HPLC and characterized by 
NMR. Encouragingly, EryMod6TE possesses broad substrate specificity, which enabled 
it to be employed as a general biocatalyst. A scaled-up reaction with a diketide priming 
unit revealed that the yields were limited to ~12% due to the competing side-reaction of 
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TE-mediated hydrolysis of the diketide substrate. TEs from other synthases were fused to 
EryMod6; while they were capable of forming pyrones, they also catalyzed hydrolysis. 
We discovered that EryMod6TE was capable of ‘‘stuttering’’, a phenomenon in which 
one module catalyzes the addition of multiple extender units to a growing polyketide. 
This ability was harnessed biocatalytically to generate the anticipated pyrones from 
monoketide substrates. 
 We also showcased a quantitative detection method that reports the fate of alkynyl 
priming units in module-catalyzed reactions within cell lysate. CuAAC with 
sulforhodamine B azide enabled normally nonchromophoric polyketide products to be 
sensitively visualized and identified using fluorescence spectroscopy and mass 
spectrometry. Employing this method, the incorporation of ethanethiol-linked priming 
and extender units into reduced diketide compounds by EryMod6TE was investigated. 
Ethanethiol handles were found to be as effective as NAC- handles. Competing 
reactivities of EryMod6TE were observed through the conversion of a β-ketoacyl 
ethanethioester priming unit to triketide lactones. We also noted an increase in enzymatic 
turnover in a single-module catalyzed reaction with increased phosphate concentrations 
and TE-mediated glycerolysis of priming units in reaction buffers containing glycerol. 
 Taken together, the works described in this dissertation have helped the scientific 
community advance towards procuring a PKS-generated library of stereochemically 
diverse molecules in vitro. We increased economic feasibility of preparative-scale 
synthesis of polyketide compounds by employing MatB-generated extender units.  We 
demonstrated the utility of EryMod6TE as a general biocatalyst of polyketide compounds 
by successfully characterizing 10 triketide pyrone compounds, attesting to the scalability 
of in vitro PKS reactions. Lastly, we developed a new, bioorthogonal, rapid, inexpensive 
and sensitive method to detect polyketide products upon CuAAC with sulforhodamine B 
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azide. This method was used to optimize reaction conditions and test the reactivites of 
domains within EryMod6TE. The work presented here has helped set the stage for the 
preparative, in vitro PKS synthesis of a library of stereoisomeric polyketides which could 
serve as chiral synthons to generate large quantities of stereochemically complex natural 
products and natural product analogs, with the ultimate goal of providing novel 
therapeutics to the infirm.  
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Appendix 1. Supporting Information for Chapter 3 
HPLC DATA FOR TE-MEDIATED HYDROLYSIS OF POLYKETIDE SUBSTRATES 
TE-mediated hydrolysis of 3.4 
 HPLC Peak Area at 235 nm 
Time (hr) Trial 1  Trial 2 Trial 3 
0 25032051 26011949 24493101 
2 12485244 12913755 12019588 
4 6711618 7548863 5860547 
6 2661936 4447764 2882410 
8 1164408 2098361 1156503 
 
Normalized Peak Area 
Trial 1 
norm. 
Trial 2 
norm. 
Trial 3 
norm. 
1 1 1 
0.50 0.50 0.49 
0.27 0.29 0.24 
0.11 0.17 0.12 
0.05 0.08 0.05 
 
 
Peak areas for EryMod6EryTE hydrolysis of 3.4 were determined using Waters BreezeTM 
2 System Software from reverse-phase chromatograms monitored at 235 nm. For each 
time trial, peak areas were normalized to 1 at time = 0 hour. Averages were plotted in 
Microsoft Excel and fit to an exponential curve. 
y = e‐0.347x R² = 0.99761 
0 0.2 
0.4 0.6 
0.8 1 
0  5  10  15  20  25 
Fr
ac
ti
on
 
Time (hr) 
Time (hr) Average St. Dev. 
0 1 0 
2 0.50 0.00 
4 0.27 0.03 
6 0.13 0.03 
8 0.06 0.02 
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TE-mediated hydrolysis of 3.7 
 HPLC Peak Area at 235 nm 
Time (hr) Trial 1  Trial 2  Trial 3 
0 8870433 7759841 13221525 
2 6849638 5871402 10787740 
4 5283320 4659478 8638482 
6 4258585 3526882 7045881 
8 3011532 3037601 6216343 
 
Normalized Peak Area 
pp1 norm. pp2 norm. pp3 norm. 
1 1 1 
0.77 0.76 0.82 
0.60 0.60 0.65 
0.48 0.45 0.53 
0.34 0.39 0.47 
 
 
Peak areas for EryMod6EryTE hydrolysis of 3.7 were determined using Waters BreezeTM 
2 System Software from reverse-phase chromatograms monitored at 235 nm. For each 
time trial, peak areas were normalized to 1 at time = 0 hour. Averages were plotted in 
Microsoft Excel and fit to an exponential curve.  
 
 
y = e‐0.117x R² = 0.99811 
0 0.2 
0.4 0.6 
0.8 1 
0  5  10  15  20  25 
Fr
ac
ti
on
 
Time (hr) 
Time (hr) Average St. Dev. 
0 1 0 
2 0.78 0.03 
4 0.62 0.03 
6 0.49 0.04 
8 0.40 0.07 
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TE-mediated hydrolysis of 3.15 
 HPLC Peak Area at 235 nm 
Time (hr) Trial 1 (p1) Trial 2 (p2) Trial 3 (p3) 
0 9018668 9011877 9812933 
2 6445475 6221437 6189349 
4.33 4471662 4387909 4841047 
6 3548422 3398701 3674209 
8 2815218 2660332 2822005 
 
Normalized Peak Area 
p1 norm. p2 norm. p3 norm. 
1 1 1 
0.71 0.69 0.63 
0.50 0.49 0.49 
0.39 0.38 0.37 
0.31 0.30 0.29 
 
 
Peak areas for EryMod6EryTE hydrolysis of 4.15 were determined using Waters Breeze-
TM 2 System Software from reverse-phase chromatograms monitored at 235 nm. For each 
time trial, peak areas were normalized to 1 at time = 0 hour. Averages were plotted in 
Microsoft Excel and fit to an exponential curve.  
y = e‐0.157x R² = 0.99018 
0 0.2 
0.4 0.6 
0.8 1 
0  5  10  15  20  25 
Fr
ac
ti
on
 
Time (hr) 
Time 
(hr) 
Average St. Dev. 
0 1 0 
2 0.68 0.04 
4.33 0.49 0.00 
6 0.38 0.01 
8 0.30 0.01 
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TE-mediated hydrolysis of 3.16 
 HPLC Peak Area at 235 nm 
Time (hr) Trial 1 (b1) Trial 2 (b2) Trial 3 (b3) 
  0 12390224 7221369 8228404 
2 10218321 5236959 6198739 
4 6806394 3512810 4075931 
6 4690121 2174455 2846014 
8 3065041 1391035 1816802 
 
Normalized Peak Area 
b1 norm. b2 norm. b3 norm. 
1 1 1 
0.82 0.73 0.75 
0.55 0.49 0.50 
0.38 0.30 0.35 
0.25 0.19 0.22 
 
 
Peak areas for EryMod6EryTE hydrolysis of 4.16 were determined using Waters Breeze-
TM 2 System Software from reverse-phase chromatograms monitored at 235 nm. For 
each time trial, peak areas were normalized to 1 at time = 0 hour. Averages were plotted 
in Microsoft Excel and fit to an exponential curve.  
 
y = e‐0.181x R² = 0.98883 
0 0.2 
0.4 0.6 
0.8 1 
0  5  10  15  20  25 
Fr
ac
ti
on
 
Time (hr) 
Time (hr) Average St. Dev. 
0 1 0 
2 0.77 0.05 
4 0.51 0.03 
6 0.34 0.04 
8 0.22 0.03 
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HPLC PEAK AREAS FOR ACTIVITY ASSAY OF ERYMOD6TE VARIANTS 
 
Experiment 1  
Raw HPLC Peak Areas of 3.11 for EryMod6TE variants 
Trial EryMod6TE EryMod6-CdaTE 
EryMod6-
RadTE 
EryMod6-
AmpTE 
1a 5261282 1314142 2428190 3077927 
2a 5528033 1392116 2490892 2839655 
3a 5500844 1431234 2607389 2932649 
AVERAGE 5430053    
 
Normalized HPLC Peak Areas to EryMod6TE Average Peak Area 
Trial EryMod6TE EryMod6-CdaTE 
EryMod6-
RadTE 
EryMod6-
AmpTE 
1a 0.969 0.242 0.447 0.567 
2a 1.018 0.256 0.459 0.523 
3a 1.013 0.264 0.480 0.540 
AVERAGE 1.000 0.254 0.462 0.543 
 
Experiment 2 
Raw and Normalized HPLC Peak Areas of 3.11 for EryMod6 
 Raw HPLC Peak Area Normalized HPLC Peak Area 
Trial EryMod6TE EryMod6 EryMod6TE EryMod6 
1b 4468906 378312 1.033 0.087 
2b 4244724 382120 0.982 0.088 
3b 4259734 356552 0.985 0.082 
AVERAGE 4324455  1.000 0.086 
 
Combined Normalized Data 
Trial EryMod6TE EryMod6-CdaTE 
EryMod6-
RadTE 
EryMod6-
AmpTE 
1a 0.969 0.242 0.447 0.567 
2a 1.018 0.256 0.459 0.523 
3a 1.013 0.264 0.480 0.540 
AVERAGE 1.000 0.254 0.462 0.543 
Standard Dev. 0.027 0.043 0.036 0.041 
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Trial EryMod6TE EryMod6 
1b 1.033 0.087 
2b 0.982 0.088 
3b 0.985 0.082 
AVERAGE 1.000 0.086 
Standard Dev. 0.029 0.037 
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1H NMR CHARACTERIZATION OF TRIKETIDE PYRONE COMPOUNDS 
 
Compound 3.8 
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Compound 3.9 
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Compound 3.10 
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Compound 3.11 
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Compound 3.12 
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Compound 3.13 
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Compound 3.20 
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13C NMR CHARACTERIZATION OF TRIKETIDE PYRONE 3.11 
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Appendix 2. Supporting Information for Chapter 4 
HPLC PEAK AREAS FOR CUAAC REACTIONS 
Compound 4.1 reaction analysis 
 
Trial 1 
 RET Time AREA % Total AREA 
4.5* 18.727 15787002 40.5 
4.4* 19.294 19825587 50.9 
4.3* 20.825 3343245 8.6 
 
Trial 2 
 RET Time AREA % Total AREA 
4.5* 18.679 16962289 40.8 
4.4* 19.249 21039755 50.6 
4.3* 20.800 3606768 8.7 
 
 
 
 
 
 
 
Compound 4.2 reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.447 11912678 33.1 
4.4* 19.030 17413347 48.5 
4.3* 20.539 6613850 18.4 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.699 15345004 34.5 
4.4* 19.270 19658811 44.1 
4.3* 20.787 9527100 21.4 
 
Compound 1 
  AVERAGE STDEV 
4.5* 40.6 0.2 
4.4* 50.7 0.2 
4.3* 8.6 0.1 
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Compound 4.1 CONTROL Reaction Analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.444 8176075 20.6 
4.3* 20.910 31563023 79.4 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.490 6260615 17.5 
4.3* 21.007 29561878 82.5 
 
 
 
 
 
 
 
Compound 4.2 CONTROL reaction analysis  
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.444 5960798 15.8 
4.3* 20.977 31720433 84.2 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.485 5514672 15.0 
4.3* 21.087 31295599 85.0 
 
Compound 4.2 
 AVERAGE STDEV 
4.5* 33.8 0.9 
4.4* 46.3 3.0 
4.3* 19.9 2.1 
Compound 4.1 CONTROL 
 AVERAGE STDEV 
4.4* 19.0 2.2 
4.3* 81.0 2.2 
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Compound 4.6 reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.13* 17.809 9013751 20.7 
4.11* 18.680 22850133 52.6 
4.6* 20.194 11593317 26.7 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.13* 17.592 8347381 16.6 
4.11* 18.484 25467750 50.8 
4.6* 19.930 16329898 32.6 
 
 
 
 
 
 
 
 
Compound 4.8 reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.13* 17.867 7061148 20.6 
4.11* 18.714 23420844 68.3 
4.8* 35.014 3821288 11.1 
 
 
 
 
Compound 4.2 CONTROL 
 AVERAGE STDEV 
4.4* 15.4 0.6 
4.3* 84.6 0.6 
Compound 4.6 
 AVERAGE STDEV 
4.13* 18.7 2.9 
4.11* 51.7 1.3 
4.6* 29.6 4.2 
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Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.13* 17.842 10990448 26.6 
4.11* 18.752 25630547 62.1 
4.8* 35.048 4675599 11.3 
 
 
 
 
 
 
 
Compound 4.6 CONTROL reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.11* 18.737 172204 0.5 
4.6* 20.024 37911066 99.5 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.11* 18.465 2424183 6.1 
4.6* 19.745 37329938 93.9 
 
 
 
 
 
 
 
 
Compound 4.8 CONTROL reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.11* 18.755 212419 0.6 
4.8* 33.681 36043103 99.4 
 
Compound 4.8 
 AVERAGE STDEV 
4.13* 23.6 4.3 
4.11* 65.2 4.4 
4.8* 11.2 0.1 
Compound 4.6 CONTROL 
 AVERAGE STDEV 
4.11* 3.3 4.0 
4.6* 96.7 4.0 
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Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.11* 18.827 2710007 6.1 
4.8* 33.460 41899558 93.9 
 
 
 
 
 
 
 
Compound 4.3 reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.620 15828462 28.3 
4.4* 19.092 33896564 60.6 
4.3* 20.719 6183995 11.1 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.464 11380788 27.1 
4.4* 19.105 23650841 56.3 
4.3* 20.509 6981340 16.6 
 
 
 
 
 
 
 
 
 
 
 
 
Compound 4.8 CONTROL 
 AVERAGE STDEV 
4.11* 3.3 3.9 
4.8* 96.7 3.9 
Compound 4.3 
 AVERAGE STDEV 
4.5* 27.7 0.9 
4.4* 58.5 3.1 
4.3* 13.8 3.9 
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Compound 4.9 reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.692 14020189 31.5 
4.4* 19.374 26711265 60.0 
4.9* 36.719 3814999 8.6 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.697 14966330 32.9 
4.4* 19.342 26192166 57.6 
4.9* 36.746 4290108 9.4 
 
 
 
 
 
 
 
Compound 4.3 CONTROL reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.359 6049863 15.9 
4.3* 20.760 31884840 84.1 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.330 6555358 16.5 
4.3* 20.849 33124632 83.5 
 
 
 
 
 
 
 
Compound 4.9 
 AVERAGE STDEV 
4.5* 32.2 1.0 
4.4* 58.8 1.6 
4.9* 9.0 0.6 
Compound 4.3 CONTROL 
 AVERAGE STDEV 
4.4* 16.2 0.4 
4.3* 83.8 0.4 
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Compound 4.9 CONTROL reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.300 594660 4.0 
4.9* 36.803 14175016 96.0 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.314 500041 2.8 
4.9* 36.754 17355117 97.2 
 
 
 
 
 
 
Compound 4.7 reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.14* 20.08 11581283 25.46 
4.12* 20.68 32761857 72.03 
4.7* 22.69 1138304 2.50 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.14* 20.16 10643821 23.85 
4.12* 20.71 33422377 74.89 
4.7* 22.70 564438 1.26 
 
 
 
 
 
 
 
 
Compound 4.9 CONTROL 
 AVERAGE STDEV 
4.4* 3.4 0.9 
4.9* 96.6 0.9 
Compound 4.7 
 AVERAGE STDEV 
4.14* 24.7 1.1 
4.12* 73.5 2.0 
4.7* 1.9 0.9 
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Compound 4.10 reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.14* 20.16 10535136 22.95 
4.12* 20.66 34727449 75.66 
4.10* 39.71 637867 1.39 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
Area 
4.14* 20.09 8001594 19.65 
4.12* 20.62 30425013 74.71 
4.10* 38.95 2299424 5.65 
 
 
 
 
 
 
 
 
Compound 4.7 CONTROL reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.12* 20.814 23100604 41.1 
4.7* 22.619 33168434 58.9 
 
Trial 2 
 Ret. Time 
(min) AREA 
%total 
AREA 
4.12* 20.655 25015046 43.3 
4.7* 22.619 32755287 56.7 
 
 
 
 
 
 
Compound 4.10 
 AVERAGE STDEV 
4.14* 21.3 2.3 
4.12* 75.2 0.7 
4.10* 3.5 3.0 
Compound 4.7 CONTROL 
 AVERAGE STDEV 
4.12* 42.2 1.6 
4.7* 57.8 1.6 
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Compound 4.10 CONTROL reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.12* 20.822 9162547 51.7 
4.10* 39.851 8562374 48.3 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.12* 20.795 12754036 62.3 
4.10* 39.769 7724401 37.7 
 
 Compound 4.10 CONTROL 
 AVERAGE STDEV 
4.12* 57.0 7.5 
4.10* 43.0 7.5 
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Compound 4.3 – 0 mM phosphate – 2 hrs - reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% 
Total 
AREA 
4.5* 18.665 14806840 21.3 
4.4* 19.232 22840606 32.8 
4.3* 20.822 31899164 45.9 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.867 13023723 22.8 
4.4* 19.407 19204279 33.5 
4.3* 20.987 25014238 43.7 
 
 
 
 
 
 
 
Compound 4.3 – 10 mM phosphate – 2 hrs - reaction analysis  
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.580 15802446 23.1 
4.4* 19.244 23049643 33.7 
4.3* 20.774 29464589 43.1 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.890 13553917 26.4 
4.4* 19.424 18227682 35.5 
4.3* 21.020 19587930 38.1 
 
 
 
 
0 mM Phosphate- 2 hrs 
 AVERAGE STDEV 
4.5* 22.0 1.0 
4.4* 33.2 0.5 
4.3* 44.8 1.5 
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Compound 4.3 – 50 mM phosphate – 2 hrs - reaction analysis  
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.464 16814392 29.4 
4.4* 19.019 21047074 36.8 
4.3* 20.539 19366060 33.8 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.777 15811837 28.8 
4.4* 19.325 19405246 35.3 
4.3* 20.905 19771894 36.0 
 
 
 
 
 
 
 
 
Compound 4.3 – 100 mM phosphate – 2 hrs - reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.492 20585641 31.5 
4.4* 19.125 28318670 43.3 
4.3* 20.640 16505850 25.2 
 
 
 
 
10 mM Phosphate- 2 hrs 
 AVERAGE STDEV 
4.5* 24.8 2.3 
4.4* 34.6 1.2 
4.3* 40.6 3.5 
50 mM Phosphate- 2 hrs 
 AVERAGE STDEV 
4.5* 29.1 0.4 
4.4* 36.0 1.1 
4.3* 34.9 1.5 
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Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.862 19556396 34.4 
4.4* 19.404 26989181 47.5 
4.3* 21.020 10325964 18.2 
 
 
 
 
 
 
 
 
Compound 4.3 – 0 mM phosphate – 16 hrs - reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.669 16536904 37.1 
4.4* 19.250 23683668 53.1 
4.3* 20.779 4360206 9.8 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.740 15832878 35.6 
4.4* 19.330 22474980 50.5 
4.3* 20.864 6184094 13.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
100 mM Phosphate - 2 hrs 
 AVERAGE STDEV 
4.5* 32.9 2.1 
4.4* 45.4 2.9 
4.3* 21.7 5.0 
0 mM Phosphate - 16 hrs 
 AVERAGE STDEV 
4.5* 36.3 1.1 
4.4* 51.8 1.8 
4.3* 11.8 2.9 
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Compound 4.3 – 10 mM phosphate – 16 hrs - reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.712 19279548 40.0 
4.4* 19.317 26531272 55.1 
4.3* 20.825 2328798 4.8 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.382 19807554 38.8 
4.4* 19.004 28157616 55.1 
4.3* 20.495 3145642 6.2 
 
 
 
 
 
 
 
 
Compound 4.3 – 50 mM phosphate – 16 hrs - reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.617 24264845 43,2 
4.4* 19.374 31903020 56.8 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.642 20931892 43.0 
4.4* 19.279 27803314 57.0 
 
10 mM Phosphate - 16 hrs 
 AVERAGE STDEV 
4.5* 39.4 0.9 
4.4* 55.1 0.0 
4.3* 5.5 0.9 
50 mM Phosphate – 16 hrs 
 AVERAGE STDEV 
4.5* 43.1 0.2 
4.4* 56.9 0.2 
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Compound 4.3 – 100 mM phosphate – 16 hrs - reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.745 22205349 42.1 
4.4* 19.300 30532660 57.9 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.5* 18.657 19918332 43.3 
4.4* 19.212 26066248 56.7 
 
 
 
 
 
 
Compound 4.3 – 0 mM phosphate – 16 hrs CONTROL reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.317 6028704 14.9 
4.3* 19.945 34549471 85.1 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.295 6749666 16.2 
4.3* 20.769 34841101 83.8 
 
100 mM Phosphate – 16 hrs 
 AVERAGE STDEV 
4.5* 42.7 0.9 
4.4* 57.3 0.9 
0 mM Phosphate CONTROL 
 AVERAGE STDEV 
4.4* 15.5 1.0 
4.3* 84.5 1.0 
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Compound 4.3 – 10 mM phosphate – 16 hrs CONTROL reaction analysis  
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.164 6257779 15.1 
4.3* 20.692 35150517 84.9 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.279 6576249 15.4 
4.3* 20.592 36009401 84.6 
 
 
 
 
 
 
Compound 4.3 – 50 mM phosphate – 16 hrs CONTROL reaction analysis  
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.275 8543020 19.9 
4.3* 20.612 34470898 80.1 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.310 7864313 18.3 
4.3* 20.894 35083973 81.7 
 
 
 
 
 
 
 
 
 
 
10 mM Phosphate CONTROL 
 AVERAGE STDEV 
4.4* 15.3 0.2 
4.3* 84.7 0.2 
50 mM Phosphate CONTROL 
 AVERAGE STDEV 
4.4* 19.1 1.1 
4.3* 80.9 1.1 
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Compound 4.3 – 100 mM phosphate – 16 hrs CONTROL reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.294 7648977 18.5 
4.3* 20.710 33648585 81.5 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.4* 19.274 9948370 23.0 
4.3* 20.677 33388648 77.0 
 
 100 mM Phosphate CONTROL 
 AVERAGE STDEV 
4.4* 20.7 3.1 
4.3* 79.3 3.1 
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Compound 4.15 reaction analysis 
 
Trial 1 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.18a* 18.590 13305217 23.8 
4.18b* 19.122 7131187 12.8 
4.20* 21.575 18279563 32.7 
4.16* 22.539 5606334 10.0 
4.19* 23.498 11526588 20.6 
 
Trial 2 
 Ret. Time 
(min) AREA 
% Total 
AREA 
4.18a* 18.845 12387653 24.4 
4.18b* 19.372 7118427 14.0 
4.20* 21.860 16615907 32.7 
4.16* 22.774 4820335 9.5 
4.19* 23.727 9887625 19.5 
 
 
 
 Compound 4.15 
 AVERAGE STDEV 
4.18a* 24.1 0.4 
4.18b* 13.4 0.9 
4.20* 32.7 0.0 
4.16* 9.8 0.4 
4.19* 20.0 0.8 
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Compound 4.3 EryMod6TE mutant reaction analysis 
 
AREA – Trial 1 
 EryMod6TE ΔKS ΔAT ΔTE 
4.21* 2614798 1554339 2198173 372883 
4.4* 826717 1509532 1235584 859962 
4.3* 3951371 4797879 3931098 5868967 
Total 
AREA 7392886 7861750 7364855 7101812 
 
 ΔKS+AT ΔKS+TE ΔAT+TE no EryMod6TE 
4.21* 1708062 479870 409617 166666 
4.4* 1138868 1127082 993593 0 
4.3* 4447477 7212606 6012292 6333238 
Total 
AREA 7294407 8819558 7415502 6499904 
 
 
 % Total Area 
 4.21* 4.4* 4.3* 
EryMod6TE 35.4 11.2 53.4 
ΔKS 19.8 19.2 61.0 
ΔAT 29.8 16.8 53.4 
ΔTE 5.2 12.1 82.6 
ΔKS+AT 23.4 15.6 61.0 
ΔKS+TE 5.4 12.8 81.8 
ΔAT+TE 5.5 13.4 81.1 
no EryMod6TE 3.0 0.0 97.4 
  
 
 
 
 
 
 
 
 
 
 125 
LC/MS characterization of sulforhodamine B adducts 
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1H NMR CHARACTERIZATION OF TERMINAL ALKYNE-CONTAINING COMPOUNDS 
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